These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the fiscal year ended December 31, 2018
|
|
|
OR
|
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from _____ to _____
|
|
|
Commission File No. 001-35517
|
|
|
Maryland
|
|
45-3148087
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
245 Park Avenue, 42nd Floor, New York, NY 10167
(Address of principal executive offices) (Zip Code)
|
||
|
(212) 750-7300
(Registrant’s telephone number, including area code)
|
||
|
Title of each class
|
|
Name of each exchange on which registered
|
|
Common Stock, $0.01 par value per share
|
|
New York Stock Exchange
|
|
Large accelerated filer
o
|
|
Accelerated filer
ý
|
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
|
Emerging growth company
o
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
our business and investment strategy;
|
|
•
|
our projected operating results;
|
|
•
|
the return or impact of current and future investments;
|
|
•
|
the timing of cash flows, if any, from our investments;
|
|
•
|
estimates relating to our ability to make distributions to our stockholders in the future;
|
|
•
|
defaults by borrowers in paying amounts due on outstanding indebtedness and our ability to collect all amounts due according to the contractual terms of our investments;
|
|
•
|
our ability to obtain and maintain financing arrangements, including securitizations;
|
|
•
|
market conditions and our ability to access alternative debt markets and additional debt and equity capital;
|
|
•
|
the amount of commercial mortgage loans requiring refinancing;
|
|
•
|
our expected investment capacity and available capital;
|
|
•
|
financing and advance rates for our target investments;
|
|
•
|
our expected leverage;
|
|
•
|
changes in interest rates, credit spreads and the market value of our investments;
|
|
•
|
the impact of changes in London Interbank Offered Rate on our operating results;
|
|
•
|
effects of hedging instruments on our target investments;
|
|
•
|
rates of default or decreased recovery rates on our target investments;
|
|
•
|
rates of prepayments on our mortgage loans and the effect on our business of such prepayments;
|
|
•
|
the degree to which our hedging strategies may or may not protect us from interest rate volatility;
|
|
•
|
availability of investment opportunities in mortgage-related and real estate-related investments and securities;
|
|
•
|
the ability of Ares Commercial Real Estate Management LLC (“ACREM” or our “Manager”) to locate suitable investments for us, monitor, service and administer our investments and execute our investment strategy;
|
|
•
|
allocation of investment opportunities to us by our Manager;
|
|
•
|
our ability to successfully identify, complete and integrate any acquisitions;
|
|
•
|
our ability to maintain our qualification as a real estate investment trust for U.S. federal income tax purposes;
|
|
•
|
our ability to maintain our exemption from registration under the Investment Company Act of 1940;
|
|
•
|
our understanding of our competition;
|
|
•
|
general volatility of the securities markets in which we may invest;
|
|
•
|
adverse changes in the real estate, real estate capital and credit markets and the impact of a protracted decline in the liquidity of credit markets on our business;
|
|
•
|
changes in governmental regulations, tax law and rates, and similar matters (including interpretation thereof);
|
|
•
|
authoritative or policy changes from standard-setting bodies such as the Financial Accounting Standards Board, the Securities and Exchange Commission, the Internal Revenue Service, the stock exchange where we list our common stock, and other authorities that we are subject to, as well as their counterparts in any foreign jurisdictions where we might do business;
|
|
•
|
actions and initiatives of the U.S. Government and changes to U.S. Government policies;
|
|
•
|
the state of the United States, European Union and Asian economies generally or in specific geographic regions;
|
|
•
|
global economic trends and economic recoveries; and
|
|
•
|
market trends in our industry, interest rates, real estate values, the debt securities markets or the general economy.
|
|
•
|
Senior Mortgage Loans:
These mortgage loans are typically secured by first liens on commercial properties, including the following property types: office, multifamily, self storage, retail, hotel, healthcare, student housing, industrial, mixed-use, residential and residential condominium. Our senior mortgage loans may include construction loans. In some cases, first lien mortgages may be divided into an A-Note and a B-Note. The A-Note is typically a privately negotiated loan that is secured by a first mortgage on a commercial property or group of related properties that is senior to a B-Note secured by the same first mortgage property or group.
|
|
•
|
Subordinated Debt:
These loans may include structurally subordinated first mortgage loans and junior participations in first mortgage loans or participations in these types of assets. As noted above, a B-Note is typically a privately negotiated loan that is secured by a first mortgage on a commercial property or group of related properties and is subordinate to an A-Note secured by the same first mortgage property or group. The subordination of a B-Note or junior participation typically is evidenced by participations or intercreditor agreements with other holders of interests in the note. B-Notes are subject to more credit risk with respect to the underlying mortgage collateral than the corresponding A-Note.
|
|
•
|
Mezzanine Loans:
Like B‑Notes, these loans are also subordinated CRE loans, but are usually secured by a pledge of the borrower’s equity ownership in the entity that owns the property or by a second lien mortgage on the property. In a liquidation, these loans are generally junior to any mortgage liens on the underlying property, but senior to any preferred equity or common equity interests in the entity that owns the property. Investor rights are usually governed by intercreditor agreements.
|
|
•
|
Preferred Equity:
Real estate preferred equity investments are subordinate to first mortgage loans and are not collateralized by the property underlying the investment. As a holder of preferred equity, we seek to enhance our position with covenants that limit the activities of the entity in which we have an interest and protect our equity by obtaining an exclusive right to control the underlying property after an event of default, should such a default occur on our investment.
|
|
•
|
Other CRE Investments:
To a lesser extent, we may invest in other loans and securities, subject to maintaining our qualification as a REIT, including but not limited to commercial mortgage-backed securities, loans to real estate or hospitality companies, debtor-in-possession loans and selected other income producing equity investments, such as triple net lease equity.
|
|
•
|
our cash flow from operations may be insufficient to make required payments of principal of and interest on the debt or we may fail to comply with all of the other covenants contained in the debt, which is likely to result in (a) acceleration of such debt (and any other debt containing a cross-default or cross-acceleration provision) that we may be unable to repay from internal funds or to refinance on favorable terms, or at all, (b) our inability to borrow unused amounts under our financing arrangements, even if we are current in payments on borrowings under those arrangements, and/or (c) the loss of some or all of our assets to foreclosure or sale;
|
|
•
|
our debt may increase our vulnerability to adverse economic and industry conditions with no assurance that investment yields will increase with higher financing costs;
|
|
•
|
we may be required to dedicate a substantial portion of our cash flow from operations to payments on our debt, thereby reducing funds available for operations, future business opportunities, stockholder distributions or other purposes;
|
|
•
|
we are not able to refinance debt that matures prior to the investment it was used to finance on favorable terms, or at all; and
|
|
•
|
as the holder of the subordinated classes of a securitization, we may be required to absorb losses.
|
|
•
|
general economic or market conditions;
|
|
•
|
the market’s view of the quality of our assets;
|
|
•
|
the market’s perception of our growth potential;
|
|
•
|
our current and potential future earnings and cash distributions; and
|
|
•
|
the market price of the shares of our common stock.
|
|
•
|
interest rate hedging can be expensive, particularly during periods of rising and volatile interest rates;
|
|
•
|
available interest rate hedges may not correspond directly with the interest rate risk for which protection is sought;
|
|
•
|
due to a credit loss, the duration of the hedge may not match the duration of the related liability;
|
|
•
|
the amount of income that a REIT may earn from hedging transactions (other than hedging transactions that satisfy certain requirements of the Code or that are done through a TRS) to offset interest rate losses is limited by U.S. federal income tax provisions governing REITs;
|
|
•
|
the credit quality of the hedging counterparty owing money on the hedge may be downgraded to such an extent that it impairs our ability to sell or assign our side of the hedging transaction; and
|
|
•
|
the hedging counterparty owing money in the hedging transaction may default on its obligation to pay.
|
|
•
|
acts of God, including earthquakes, floods and other natural disasters, which may result in uninsured losses;
|
|
•
|
political events, acts of war or terrorism, including the consequences of terrorist attacks;
|
|
•
|
adverse changes in national and local economic and market conditions, including local markets with a significant exposure to the energy sector, which may be affected by the current low prices of oil and related gas that could adversely affect the success of tenants in that industry;
|
|
•
|
changes in governmental laws and regulations (including their interpretations), fiscal policies and zoning ordinances and the related costs of compliance with laws and regulations, fiscal policies and ordinances;
|
|
•
|
costs of remediation and liabilities associated with environmental conditions such as indoor mold; and
|
|
•
|
the potential for uninsured or under-insured property losses.
|
|
•
|
tenant mix;
|
|
•
|
success of tenant businesses;
|
|
•
|
property management decisions;
|
|
•
|
property location, condition and design;
|
|
•
|
competition from comparable types of properties;
|
|
•
|
changes in laws that increase operating expenses or limit rents that may be charged;
|
|
•
|
changes in national, regional or local economic conditions and/or specific industry segments, including the credit and securitization markets;
|
|
•
|
declines in regional or local real estate values;
|
|
•
|
changes in local markets in which our tenants operate, including changes in oil and gas prices;
|
|
•
|
declines in regional or local rental or occupancy rates;
|
|
•
|
increases in interest rates, real estate tax rates and other operating expenses;
|
|
•
|
costs of remediation and liabilities associated with environmental conditions;
|
|
•
|
the potential for uninsured or underinsured property losses;
|
|
•
|
the potential for casualty or condemnation loss;
|
|
•
|
changes in governmental laws and regulations, including fiscal policies, zoning ordinances and environmental legislation and the related costs of compliance;
|
|
•
|
changes in supply (resulting from the recent growth in CRE debt funds or otherwise) and demand; and
|
|
•
|
acts of God, terrorist attacks, social unrest and civil disturbances.
|
|
•
|
our actual or projected operating results, financial condition, cash flows and liquidity, or changes in business strategy or prospects;
|
|
•
|
actual or perceived conflicts of interest with our Manager or Ares Management and individuals, including our executives;
|
|
•
|
equity issuances by us, or share resales by our stockholders, or the perception that such issuances or resales may occur;
|
|
•
|
loss of a major funding source;
|
|
•
|
actual or anticipated accounting problems;
|
|
•
|
publication of research reports about us or the real estate industry;
|
|
•
|
changes in market valuations of similar companies;
|
|
•
|
adverse market reaction to any increased indebtedness we incur in the future;
|
|
•
|
additions to or departures of our Manager’s or Ares Management’s key personnel;
|
|
•
|
speculation in the press or investment community;
|
|
•
|
increases in market interest rates and widening of market credit spreads, which may lead investors to demand a higher distribution yield for our common stock and would result in increased interest expenses on our debt;
|
|
•
|
failure to maintain our REIT qualification or exemption from the 1940 Act;
|
|
•
|
price and volume fluctuations in the overall stock market from time to time;
|
|
•
|
general market and economic conditions, and trends including inflationary concerns, the current state of the credit and capital markets;
|
|
•
|
significant volatility in the market price and trading volume of securities of publicly traded REITs or other companies in our sector, which are not necessarily related to the operating performance of these companies;
|
|
•
|
changes in law, regulatory policies or tax guidelines, or interpretations thereof, particularly with respect to REITs;
|
|
•
|
changes in the value of our portfolio;
|
|
•
|
any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts;
|
|
•
|
operating performance of companies comparable to us;
|
|
•
|
short-selling pressure with respect to shares of our common stock or REITs generally;
|
|
•
|
uncertainty surrounding the continued strength of the U.S. economy; and
|
|
•
|
concerns regarding volatility in the U.S. and global financial markets.
|
|
•
|
our ability to make profitable investments;
|
|
•
|
margin calls or other expenses that reduce our cash flow;
|
|
•
|
defaults in our asset portfolio or decreases in the value of our portfolio; and
|
|
•
|
the fact that anticipated operating expense levels may not prove accurate, as actual results may vary from estimates.
|
|
•
|
80% of the votes entitled to be cast by holders of the then-outstanding shares of voting stock of the corporation; and
|
|
•
|
two-thirds of the votes entitled to be cast by holders of voting stock of the corporation, other than shares held by the interested stockholder with whom or with whose affiliate the business combination is to be effected, or held by an affiliate or associate of the interested stockholder.
|
|
•
|
the election or removal of directors;
|
|
•
|
the amendment of our charter, except that our board of directors may amend our charter without stockholder approval to:
|
|
•
|
change our name;
|
|
•
|
change the name or other designation or the par value of any class or series of stock and the aggregate par value of our stock;
|
|
•
|
increase or decrease the aggregate number of shares of stock that we have the authority to issue;
|
|
•
|
increase or decrease the number of shares of any class or series of stock that we have the authority to issue; and
|
|
•
|
effect certain reverse stock splits;
|
|
•
|
our dissolution; and
|
|
•
|
our being a party to a merger, consolidation, conversion, sale or other disposition of all or substantially all of our assets or statutory share exchange.
|
|
SOURCE:
|
S&P Global Market Intelligence
|
|
NOTES:
|
Assumes $100 invested on December 31, 2013 in ACRE, the S&P 500 Index and the SNL US Finance REIT Index. Assumes all dividends are reinvested on the respective dividend payment dates without commissions.
|
|
|
12/31/13
|
|
12/31/14
|
|
12/31/15
|
|
12/31/16
|
|
12/31/17
|
|
12/31/18
|
||||||
|
ACRE
|
100.00
|
|
|
94.78
|
|
|
102.59
|
|
|
134.23
|
|
|
136.37
|
|
|
149.84
|
|
|
S&P 500 Index
|
100.00
|
|
|
113.69
|
|
|
115.26
|
|
|
129.05
|
|
|
157.22
|
|
|
150.33
|
|
|
SNL US Finance REIT Index
|
100.00
|
|
|
114.52
|
|
|
105.02
|
|
|
129.36
|
|
|
150.94
|
|
|
145.09
|
|
|
Plan Category
|
|
Number of
securities to be issued upon exercise of outstanding options, warrants and rights |
|
Weighted-
average exercise price of outstanding options, warrants and rights |
|
Number of
securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column of this table)(1) |
||||
|
Equity compensation plans approved by stockholders
|
|
—
|
|
|
$
|
—
|
|
|
894,244
|
|
|
Equity compensation plans not approved by stockholders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
|
—
|
|
|
$
|
—
|
|
|
894,244
|
|
|
(1)
|
The securities shown in this column may be issued as restricted stock, restricted stock units and/or other equity-based awards to eligible awardees under our Amended and Restated 2012 Equity Incentive Plan.
|
|
|
For the years ended December 31,
|
||||||||||||||||||
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
|
Operating Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net interest margin, excluding non-controlling interests held by third parties
|
$
|
55,282
|
|
|
$
|
46,313
|
|
|
$
|
40,568
|
|
|
$
|
40,936
|
|
|
$
|
36,551
|
|
|
Gain on sale of loans
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
680
|
|
|||||
|
Total expenses
|
16,240
|
|
|
14,970
|
|
|
14,426
|
|
|
13,671
|
|
|
14,549
|
|
|||||
|
Early extinguishment of debt costs
|
—
|
|
|
(768
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Net income from continuing operations
|
38,596
|
|
|
30,432
|
|
|
30,451
|
|
|
36,335
|
|
|
22,749
|
|
|||||
|
Net income from operations of discontinued operations, net of income taxes
|
—
|
|
|
—
|
|
|
4,221
|
|
|
6,985
|
|
|
1,867
|
|
|||||
|
Gain on sale of discontinued operations
|
—
|
|
|
—
|
|
|
10,196
|
|
|
—
|
|
|
—
|
|
|||||
|
Net income attributable to common stockholders
|
$
|
38,596
|
|
|
$
|
30,407
|
|
|
$
|
40,336
|
|
|
$
|
34,285
|
|
|
$
|
24,396
|
|
|
Basic weighted average shares of common stock outstanding
|
28,529,439
|
|
|
28,478,237
|
|
|
28,461,853
|
|
|
28,501,897
|
|
|
28,459,309
|
|
|||||
|
Diluted weighted average shares of common stock outstanding
|
28,656,660
|
|
|
28,550,945
|
|
|
28,523,306
|
|
|
28,597,568
|
|
|
28,585,022
|
|
|||||
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Continuing operations
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
$
|
0.96
|
|
|
$
|
0.79
|
|
|
Discontinued operations
|
—
|
|
|
—
|
|
|
0.51
|
|
|
0.25
|
|
|
0.07
|
|
|||||
|
Net income
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
1.42
|
|
|
$
|
1.20
|
|
|
$
|
0.86
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Continuing operations
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
$
|
0.95
|
|
|
$
|
0.79
|
|
|
Discontinued operations
|
—
|
|
|
—
|
|
|
0.51
|
|
|
0.24
|
|
|
0.07
|
|
|||||
|
Net income
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
1.41
|
|
|
$
|
1.20
|
|
|
$
|
0.85
|
|
|
Dividends declared per share of common stock
|
$
|
1.16
|
|
|
$
|
1.08
|
|
|
$
|
1.04
|
|
|
$
|
1.00
|
|
|
$
|
1.00
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Loans held for investment
|
$
|
1,524,873
|
|
|
$
|
1,726,283
|
|
|
$
|
1,313,937
|
|
|
$
|
1,174,391
|
|
|
$
|
1,462,584
|
|
|
Total assets
|
1,603,324
|
|
|
1,770,219
|
|
|
1,373,703
|
|
|
1,378,982
|
|
|
1,862,155
|
|
|||||
|
Secured funding agreements
|
777,974
|
|
|
957,960
|
|
|
780,713
|
|
|
522,775
|
|
|
552,799
|
|
|||||
|
Secured term loan
|
108,345
|
|
|
107,595
|
|
|
149,878
|
|
|
69,762
|
|
|
—
|
|
|||||
|
Total unsecured debt
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
67,414
|
|
|||||
|
Total securitizations debt
|
270,737
|
|
|
271,211
|
|
|
—
|
|
|
254,343
|
|
|
523,229
|
|
|||||
|
Total liabilities
|
1,177,737
|
|
|
1,351,049
|
|
|
944,030
|
|
|
922,494
|
|
|
1,381,269
|
|
|||||
|
Total stockholders' equity
|
425,587
|
|
|
419,170
|
|
|
419,029
|
|
|
409,471
|
|
|
402,954
|
|
|||||
|
Total equity
|
425,587
|
|
|
419,170
|
|
|
429,673
|
|
|
456,488
|
|
|
480,886
|
|
|||||
|
•
|
ACRE originated a $16.7 million senior mortgage loan on the construction of a residential property located in California.
|
|
•
|
ACRE originated a $21.7 million senior mortgage loan on a multifamily property located in California.
|
|
•
|
ACRE originated a $56.1 million senior mortgage loan on a mixed-use property located in California.
|
|
•
|
ACRE exercised a 12-month extension option on the CNB Facility (as defined below) to extend the initial maturity date to March 10, 2019. ACRE has one additional 12-month extension option, which, if exercised, would extend the maturity date of the CNB Facility to March 10, 2020.
|
|
•
|
ACRE originated a $39.2 million senior mortgage loan on a multifamily property located in South Carolina.
|
|
•
|
ACRE originated a $32.9 million senior mortgage loan on a hotel property located in Illinois.
|
|
•
|
ACRE originated a $68.1 million senior mortgage loan on a portfolio of hotel properties located in Oregon and Washington.
|
|
•
|
ACRE originated a $15.3 million mezzanine loan on the construction of a mixed-use property located in Illinois.
|
|
•
|
ACRE originated a $59.6 million senior mortgage loan on an office property located in Illinois.
|
|
•
|
ACRE amended the BAML Facility (as defined below), which has a commitment amount of $125.0 million, to extend the period during which we may request individual loans under the facility to May 23, 2019. In addition, the final maturity date of individual loans under the BAML Facility was extended to May 23, 2022.
|
|
•
|
ACRE originated a $31.5 million senior mortgage loan on a hotel property located in Minnesota.
|
|
•
|
ACRE originated an $8.0 million pre-construction mezzanine loan on a property with in-place development rights for a residential condominium project located in Hawaii.
|
|
•
|
ACRE originated a $78.0 million senior mortgage loan on a hotel portfolio located across multiple states.
|
|
•
|
ACRE originated a $17.5 million pre-construction senior mortgage loan on a property with in-place development rights for a residential condominium project located in Florida.
|
|
•
|
ACRE originated a $14.0 million mezzanine construction loan on a property with in-place development rights for a residential condominium conversion project located in New York.
|
|
•
|
ACRE originated a $13.5 million senior mortgage loan on an office property located in North Carolina.
|
|
•
|
ACRE originated a $22.9 million senior mortgage loan on an office property located in California.
|
|
•
|
ACRE originated a $40.0 million senior mortgage loan on a multifamily property located in Illinois.
|
|
•
|
ACRE originated a $30.3 million senior mortgage loan on a multifamily property located in Pennsylvania.
|
|
•
|
ACRE originated a $43.5 million senior mortgage loan on a multifamily property located in Florida.
|
|
•
|
ACRE amended the Wells Fargo Facility (as defined below), which has a commitment amount of $500.0 million, to extend the initial maturity date to December 14, 2020 and decrease the interest rate on advances from a per annum rate equal to the sum of one-month LIBOR plus a pricing margin range of 1.75% to 2.35% to a per annum rate equal to the sum of one-month LIBOR plus a pricing margin range of 1.50% to 2.25%. The initial maturity date of the Wells Fargo Facility is subject to three 12-month extensions, each of which may be exercised at ACRE’s option, subject to the satisfaction of certain conditions, including payment of an extension fee, which, if all three were exercised, would extend the maturity date of the Wells Fargo Facility to December 14, 2023.
|
|
•
|
ACRE amended the Citibank Facility (as defined below) to increase the facility’s commitment amount from $250.0 million to $325.0 million and extend the initial maturity date to December 13, 2021. The initial maturity date of the Citibank Facility is subject to two 12-month extensions, each of which may be exercised at ACRE’s option assuming no existing defaults under the Citibank Facility and applicable extension fees being paid, which, if both were exercised, would extend the maturity date of the Citibank Facility to December 13, 2023. In addition, ACRE amended the Citibank Facility to decrease the interest rate on advances from a per annum rate equal to the sum of one-month LIBOR plus an indicative pricing margin range of 2.25% to 2.50%, subject to certain exceptions, to a per annum rate equal to the sum of one-month LIBOR plus an indicative pricing margin range of 1.50% to 2.25%, subject to certain exceptions.
|
|
•
|
the interest expense associated with our borrowings to increase, subject to any applicable ceilings;
|
|
•
|
the value of our mortgage loans to decline;
|
|
•
|
coupons on our floating rate mortgage loans to reset to higher interest rates; and
|
|
•
|
to the extent we enter into interest rate swap agreements as part of our hedging strategy where we pay fixed and receive floating interest rates, the value of these agreements to increase.
|
|
•
|
the interest expense associated with our borrowings to decrease, subject to any applicable floors;
|
|
•
|
the value of our mortgage loan portfolio to increase, for such mortgages with applicable floors;
|
|
•
|
coupons on our floating rate mortgage loans to reset to lower interest rates, subject to any applicable floors; and
|
|
•
|
to the extent we enter into interest rate swap agreements as part of our hedging strategy where we pay fixed and receive floating interest rates, the value of these agreements to decrease.
|
|
|
As of December 31, 2018
|
||||||||||||||
|
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Minimum Loan Borrowing Spread (2)
|
|
Weighted Average Unleveraged Effective Yield (3)
|
|
Weighted Average Remaining Life (Years)
|
||||||
|
Senior mortgage loans
|
$
|
1,489,708
|
|
|
$
|
1,498,530
|
|
|
5.2
|
%
|
|
7.0
|
%
|
|
1.7
|
|
Subordinated debt and preferred equity investments
|
35,165
|
|
|
36,213
|
|
|
12.7
|
%
|
|
14.9
|
%
|
|
4.3
|
||
|
Total loans held for investment portfolio
|
$
|
1,524,873
|
|
|
$
|
1,534,743
|
|
|
5.4
|
%
|
|
7.1
|
%
|
|
1.8
|
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
|
|
(2)
|
Minimum Loan Borrowing Spread is equal to (a) for floating rate loans, the margin above the applicable index rate (e.g., LIBOR) plus floors, if any, on such applicable index rates, and (b) for fixed rate loans, the applicable interest rate.
|
|
(3)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes
no
dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by us as of
December 31, 2018
as weighted by the outstanding principal balance of each loan.
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net interest margin
|
$
|
55,282
|
|
|
$
|
46,348
|
|
|
$
|
45,107
|
|
|
Total expenses
|
16,240
|
|
|
14,970
|
|
|
14,426
|
|
|||
|
Early extinguishment of debt costs
|
—
|
|
|
(768
|
)
|
|
—
|
|
|||
|
Income from continuing operations before income taxes
|
39,042
|
|
|
30,610
|
|
|
30,681
|
|
|||
|
Income tax expense, including excise tax
|
446
|
|
|
178
|
|
|
230
|
|
|||
|
Net income from continuing operations
|
38,596
|
|
|
30,432
|
|
|
30,451
|
|
|||
|
Net income from operations of discontinued operations, net of income taxes
|
—
|
|
|
—
|
|
|
4,221
|
|
|||
|
Gain on sale of discontinued operations
|
—
|
|
|
—
|
|
|
10,196
|
|
|||
|
Net income attributable to ACRE
|
38,596
|
|
|
30,432
|
|
|
44,868
|
|
|||
|
Less: Net income attributable to non-controlling interests
|
—
|
|
|
(25
|
)
|
|
(4,532
|
)
|
|||
|
Net income attributable to common stockholders
|
$
|
38,596
|
|
|
$
|
30,407
|
|
|
$
|
40,336
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Interest income from loans held for investment
|
$
|
118,284
|
|
|
$
|
97,541
|
|
|
$
|
81,963
|
|
|
Interest expense
|
(63,002
|
)
|
|
(51,193
|
)
|
|
(36,856
|
)
|
|||
|
Net interest margin
|
$
|
55,282
|
|
|
$
|
46,348
|
|
|
$
|
45,107
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Management and incentive fees to affiliate
|
$
|
7,418
|
|
|
$
|
6,569
|
|
|
$
|
5,956
|
|
|
Professional fees
|
1,945
|
|
|
1,674
|
|
|
2,228
|
|
|||
|
General and administrative expenses
|
3,307
|
|
|
2,828
|
|
|
2,801
|
|
|||
|
General and administrative expenses reimbursed to affiliate
|
3,570
|
|
|
3,899
|
|
|
3,441
|
|
|||
|
Total expenses
|
$
|
16,240
|
|
|
$
|
14,970
|
|
|
$
|
14,426
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net income
|
$
|
38,596
|
|
|
$
|
30,432
|
|
|
$
|
44,868
|
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
622
|
|
|
844
|
|
|
(49,358
|
)
|
|||
|
Net cash provided by (used in) operating activities
|
39,218
|
|
|
31,276
|
|
|
(4,490
|
)
|
|||
|
Net cash provided by (used in) investing activities
|
157,924
|
|
|
(405,768
|
)
|
|
(60,297
|
)
|
|||
|
Net cash provided by (used in) financing activities
|
(214,396
|
)
|
|
355,569
|
|
|
73,057
|
|
|||
|
Change in cash, cash equivalents and restricted cash
|
$
|
(17,254
|
)
|
|
$
|
(18,923
|
)
|
|
$
|
8,270
|
|
|
|
|
As of December 31,
|
|||||||||||||||||||||||
|
|
|
2018
|
|
2017
|
|
||||||||||||||||||||
|
|
|
Total
Commitment |
|
Outstanding Balance
|
|
Interest Rate
|
|
Maturity Date
|
|
Total
Commitment |
|
Outstanding Balance
|
|
Interest Rate
|
|
Maturity Date
|
|
||||||||
|
Secured Funding Agreements:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Wells Fargo Facility
|
|
$
|
500,000
|
|
|
$
|
274,071
|
|
|
LIBOR+1.50 to 2.25%
|
|
December 14, 2020
|
(1)
|
$
|
500,000
|
|
|
$
|
407,853
|
|
|
LIBOR+1.75 to 2.35%
|
|
December 14, 2018
|
(1)
|
|
Citibank Facility
|
|
325,000
|
|
|
184,003
|
|
|
LIBOR+1.50 to 2.50%
|
|
December 13, 2021
|
(2)
|
250,000
|
|
(2)
|
175,651
|
|
|
LIBOR+2.25 to 2.50%
|
|
December 10, 2018
|
(2)
|
||||
|
BAML Facility
|
|
125,000
|
|
|
36,280
|
|
|
LIBOR+2.00%
|
|
May 23, 2019
|
(3)
|
125,000
|
|
|
78,320
|
|
|
LIBOR+2.00%
|
|
May 24, 2018
|
(3)
|
||||
|
CNB Facility
|
|
50,000
|
|
|
—
|
|
|
LIBOR+3.00%
|
|
March 10, 2019
|
(4)
|
50,000
|
|
|
—
|
|
|
LIBOR+3.00%
|
|
March 11, 2018
|
(4)
|
||||
|
MetLife Facility
|
|
180,000
|
|
|
135,145
|
|
|
LIBOR+2.30%
|
|
August 12, 2020
|
(5)
|
180,000
|
|
|
101,131
|
|
|
LIBOR+2.30%
|
|
August 12, 2020
|
(5)
|
||||
|
UBS Facility
|
|
—
|
|
|
—
|
|
|
—
|
|
—
|
(6)
|
140,000
|
|
|
34,000
|
|
|
LIBOR+1.88 to 2.28%
|
(6)
|
October 21, 2018
|
|
||||
|
U.S. Bank Facility
|
|
185,989
|
|
|
148,475
|
|
|
LIBOR+1.75 to 2.25%
|
|
July 31, 2020
|
(7)
|
185,989
|
|
|
161,005
|
|
|
LIBOR+1.85 to 2.25%
|
|
July 31, 2020
|
(7)
|
||||
|
Subtotal
|
|
$
|
1,365,989
|
|
|
$
|
777,974
|
|
|
|
|
|
|
$
|
1,430,989
|
|
|
$
|
957,960
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Secured Term Loan
|
|
$
|
110,000
|
|
|
$
|
110,000
|
|
|
LIBOR+5.00%
|
|
December 22, 2020
|
(8)
|
$
|
110,000
|
|
|
$
|
110,000
|
|
|
LIBOR+5.00%
|
|
December 22, 2020
|
(8)
|
|
Total
|
|
$
|
1,475,989
|
|
|
$
|
887,974
|
|
|
|
|
|
|
$
|
1,540,989
|
|
|
$
|
1,067,960
|
|
|
|
|
|
|
|
(1)
|
The maturity date of the master repurchase funding facility with Wells Fargo Bank, National Association (the “Wells Fargo Facility”) is subject to three 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. In December 2018, we amended the Wells Fargo Facility to extend the initial maturity date to December 14, 2020 and decrease the interest rate on advances to a per annum rate equal to the sum of one-month LIBOR plus a pricing margin range of 1.50% to 2.25%.
|
|
(2)
|
The maturity date of the master repurchase facility with Citibank, N.A. (the “Citibank Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. As of December 31, 2017, the Citibank Facility had an accordion feature that provided for an increase in the $250.0 million commitment amount with respect to approved assets, as determined by Citibank, N.A. in its sole discretion. In December 2018, we amended the Citibank Facility to increase the facility’s commitment amount from $250.0 million to $325.0 million, extend the initial maturity date to December 13, 2021, decrease the interest rate on advances to a per
|
|
(3)
|
Individual advances on loans under the Bridge Loan Warehousing Credit and Security Agreement with Bank of America, N.A. (the “BAML Facility”) generally have a two-year maturity, subject to a 12-month extension at our option provided that certain conditions are met and applicable extension fees are paid. In May 2018, we amended the BAML Facility to extend the period during which we may request individual loans under the facility to May 23, 2019. In addition, the final maturity date of individual loans under the BAML Facility was extended to May 23, 2022.
|
|
(4)
|
The maturity date of the secured revolving funding facility with City National Bank (the “CNB Facility”) is subject to one 12-month extension at our option provided that certain conditions are met and applicable extension fees are paid. In February 2018, we exercised a 12-month extension option on the CNB Facility to extend the maturity date to March 10, 2019.
|
|
(5)
|
The maturity date of the revolving master repurchase facility with Metropolitan Life Insurance Company (the “MetLife Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid.
|
|
(6)
|
The interest rate on advances under the revolving master repurchase facility with UBS Real Estate Securities Inc. (the “UBS Facility”) was the sum of one-month LIBOR plus (i) 1.88% per annum, for assets that were subject to an advance for one year or less, (ii) 2.08% per annum, for assets that were subject to an advance in excess of one year but less than two years, and (iii) 2.28% per annum, for assets that were subject to an advance for more than two years. In October 2018, the UBS Facility matured. The UBS Facility had been repaid in full and its term was not extended.
|
|
(7)
|
The maturity date of the master repurchase and securities contract with U.S. Bank National Association (the “U.S. Bank Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid.
|
|
(8)
|
The maturity date of the Credit and Guaranty Agreement with the lenders referred to therein and Cortland Capital Market Services LLC, as administrative agent and collateral agent for the lenders (the “Secured Term Loan”), is subject to one 12-month extension at our option provided that certain conditions are met.
|
|
|
Total
|
|
Less than
1 year |
|
1 to 3 years
|
|
3 to 5 years
|
|
More than
5 years |
||||||||||
|
Wells Fargo Facility
|
$
|
274,071
|
|
|
$
|
—
|
|
|
$
|
274,071
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Citibank Facility
|
184,003
|
|
|
—
|
|
|
184,003
|
|
|
—
|
|
|
—
|
|
|||||
|
BAML Facility
|
36,280
|
|
|
36,280
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
CNB Facility
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
MetLife Facility
|
135,145
|
|
|
—
|
|
|
135,145
|
|
|
—
|
|
|
—
|
|
|||||
|
U.S. Bank Facility
|
148,475
|
|
|
—
|
|
|
148,475
|
|
|
—
|
|
|
—
|
|
|||||
|
Secured Term Loan
|
110,000
|
|
|
—
|
|
|
110,000
|
|
|
—
|
|
|
—
|
|
|||||
|
Future Loan Funding Commitments
|
142,872
|
|
|
13,055
|
|
|
122,052
|
|
|
7,765
|
|
|
—
|
|
|||||
|
Total
|
$
|
1,030,846
|
|
|
$
|
49,335
|
|
|
$
|
973,746
|
|
|
$
|
7,765
|
|
|
$
|
—
|
|
|
Change in Average 30-Day LIBOR
|
|
For the year ended December 31, 2018
|
||
|
Up 300 basis points
|
|
$
|
11.4
|
|
|
Up 200 basis points
|
|
$
|
7.6
|
|
|
Up 100 basis points
|
|
$
|
3.8
|
|
|
Down to 0 basis points
|
|
$
|
8.2
|
|
|
1.
|
Financial Statements—See the Index to Consolidated Financial Statements on Page F-1.
|
|
2.
|
Financial Statement Schedules—None. We have omitted financial statement schedules because they are not required or are not applicable, or the required information is shown in the consolidated financial statements or notes to the consolidated financial statements.
|
|
3.
|
Exhibits.
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
*
|
Purchase and Sale Agreement, among Ares Commercial Real Estate Corporation and Cornerstone Real Estate Advisers LLC.(1)
|
|
|
*
|
Waiver and Amendment to Purchase and Sale Agreement, dates as of September 29, 2016, among Ares Commercial Real Estate Corporation and Barings Real Estate Advisers LLC (formerly known as Cornerstone Real Estate Advisers LLC).(24)
|
|
|
*
|
Articles of Amendment and Restatement of Ares Commercial Real Estate Corporation.(2)
|
|
|
*
|
Amended and Restated Bylaws of Ares Commercial Real Estate Corporation.(3)
|
|
|
*
|
Registration Rights Agreement, dated April 25, 2012, between Ares Commercial Real Estate Corporation and Ares Investments Holdings LLC.(4)
|
|
|
*
|
Management Agreement, dated April 25, 2012, between Ares Commercial Real Estate Management LLC and Ares Commercial Real Estate Corporation.(5)
|
|
|
*
|
Trademark License Agreement, dated April 25, 2012, between Ares Commercial Real Estate Corporation and Ares Management LLC.(4)
|
|
|
*
|
Amended and Restated 2012 Equity Incentive Plan.(34)#
|
|
|
*
|
Form of Restricted Stock Agreement.(6)#
|
|
|
*
|
Form of Restricted Stock Agreement with officers.(34)#
|
|
|
*
|
Form of Indemnification Agreement with directors and certain officers.(4)#
|
|
|
*
|
Form of Indemnification Agreement with members of the Investment Committee and/or Underwriting Committee of Ares Commercial Real Estate Management LLC.(4)#
|
|
|
*
|
Registration Rights Agreement, dated as of August 30, 2013, among Ares Commercial Real Estate Corporation, Alliant Inc. and The Alliant Company, LLC.(7)
|
|
|
*
|
Credit Agreement, dated as of March 12, 2014, by and among ACRC Lender LLC, as borrower, City National Bank, a national banking association, as arranger and administrative agent, and the lenders party thereto.(8)
|
|
|
*
|
General Continuing Guaranty, dated as of March 12, 2014, by Ares Commercial Real Estate Corporation, as guarantor, in favor of City National Bank, a national banking association, as arranger and administrative agent.(8)
|
|
|
*
|
Security Agreement, dated as of March 12, 2014, by ACRC Lender LLC, as borrower, in favor of City National Bank, a national banking association, as arranger and administrative agent.(8)
|
|
|
*
|
Intercompany Subordination Agreement, dated as of March 12, 2014, by and among ACRC Lender LLC, as borrower, and Ares Commercial Real Estate Corporation, as guarantor, in favor of City National Bank, a national banking association, as arranger and administrative agent.(8)
|
|
|
*
|
Master Repurchase Agreement, dated as of April 9, 2014, among ACRC Lender U LLC and ACRC Lender U TRS LLC, as sellers, ACRC Lender U Mezz LLC, as mezzanine subsidiary, Ares Commercial Real Estate Corporation, as guarantor, and UBS Real Estate Securities Inc., as buyer.(9)
|
|
|
*
|
Guaranty Agreement, dated as of April 9, 2014, by Ares Commercial Real Estate Corporation in favor of UBS Real Estate Securities Inc.(9)
|
|
|
*
|
Master Repurchase Agreement, dated as of August 13, 2014, between ACRC Lender ML LLC, as seller, and Metropolitan Life Insurance Company, as buyer.(10)
|
|
|
*
|
Guaranty, dated as of August 13, 2014, by Ares Commercial Real Estate Corporation in favor of Metropolitan Life Insurance Company.(10)
|
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
*
|
Master Repurchase Agreement, dated as of December 8, 2014, by and between ACRC Lender C LLC, as seller, and Citibank, N.A., as buyer.(11)
|
|
|
*
|
Omnibus Amendment To Other Transaction Documents and Reaffirmation of Guaranty, dated as of December 8, 2014, by and among ACRC Lender C LLC, ACRC Lender LLC, Ares Commercial Real Estate Corporation and Citibank, N.A.(11)
|
|
|
*
|
Amendment Number One to Credit Agreement and Consent, dated as of July 30, 2014, by and among ACRC Lender LLC, as borrower, City National Bank, a national banking association, as arranger and administrative agent, and the lenders party thereto.(12)
|
|
|
*
|
Bridge Loan Warehousing Credit and Security Agreement, dated as of May 27, 2015, by and among ACRC Lender B LLC, Bank of America, N.A., as Administrative Agent and Lender and the other Lenders.(13)
|
|
|
*
|
Guaranty Agreement, dated as of May 27, 2015, by Ares Commercial Real Estate Corporation, in favor of Bank of America, N.A., as Administrative Agent and Lender and for the benefit of the other Lenders.(13)
|
|
|
*
|
Pledge and Security Agreement, dated as of May 27, 2015, by and between ACRC Lender LLC and Bank of America, N.A., as Administrative Agent and Lender and for the benefit of the other Lenders.(13)
|
|
|
*
|
Amendment No. 2 to Master Repurchase Agreement dated as of October 21, 2015, among ACRC Lender U LLC and ACRC Lender U TRS LLC, as sellers, ACRC Lender U Mezz LLC, as mezzanine subsidiary, Ares Commercial Real Estate Corporation, as guarantor and UBS Real Estate Securities, Inc., as buyer.(14)
|
|
|
*
|
Credit and Guaranty Agreement, dated as of December 9, 2015 by and among Ares Commercial Real Estate Corporation, as borrower and ACRC Holdings LLC, ACRC Mezz Holdings LLC, ACRC CP Investor LLC and ACRC Warehouse Holdings LLC, as guarantors, the lenders party thereto, Highbridge Principal Strategies, LLC, as administrative agent and DBD Credit Funding LLC, as collateral agent.(15)
|
|
|
*
|
Pledge and Security Agreement, dated as of December 9, 2015 among Ares Commercial Real Estate Corporation, ACRC Holdings LLC, ACRC Mezz Holdings LLC, ACRC CP Investor LLC, ACRC Warehouse Holdings LLC and ACRC Lender and DBD Credit Funding LLC, as collateral agent for the lenders.(15)
|
|
|
*
|
Negative Pledge Agreement, dated as of December 9, 2015 by Ares Commercial Real Estate Corporation, ACRC KA JV Investor LLC, ACRC Lender LLC, ACRC Champions Investor LLC and ACRE Capital Holdings LLC in favor of DBD Credit Funding LLC, as collateral agent for the lenders.(15)
|
|
|
*
|
Amendment No. 2 to Bridge Loan Warehousing Credit and Security Agreement dated as of February 26, 2016, among ACRC Lender B LLC and Bank Of America, N.A.(16)
|
|
|
*
|
Amendment No. 3 to Credit Agreement dated as of February 26, 2016, by and among ACRC Lender LLC, as borrower, City National Bank, a national banking association, as arranger and administrative agent, and the lenders party thereto.(16)
|
|
|
*
|
Amendment No. 3 to Bridge Loan Warehousing Credit and Security Agreement dated as of May 26, 2016, among ACRC Lender B LLC and Bank of America, N.A.(17)
|
|
|
*
|
First Amendment to Master Repurchase Agreement and Guaranty dated as of July 13, 2016, among ACRC Lender C LLC, as borrower, Ares Commercial Real Estate Corporation, as guarantor, and Citibank, N.A., as lender.(18)
|
|
|
*
|
Second Amendment to Master Repurchase Agreement and Guaranty dated as of July 13, 2016, among ACRC Lender C LLC, as borrower, Ares Commercial Real Estate Corporation, as guarantor, and Citibank, N.A., as lender.(19)
|
|
|
*
|
Amendment No. 2 to Credit Agreement dated as of July 29, 2016, by and among ACRC Lender LLC, City National Bank, a national banking association, as arranger and administrative agent, and the lenders party thereto.(18)
|
|
|
*
|
Master Repurchase and Securities Contract dated as of August 1, 2016, between ACRC Lender US LLC and U.S. Bank National Association.(18)
|
|
|
*
|
Payment Guaranty, dated as of August 1, 2016, by Ares Commercial Real Estate Corporation in favor of U.S. Bank National Association.(18)
|
|
|
*
|
Amended and Restated Bridge Loan Warehousing Credit and Security Agreement, dated as of August 8, 2016, by and among ACRC Lender B LLC, Bank of America, N.A., as Administrative Agent and Lender and the other Lenders.(20)
|
|
|
*
|
Amendment to Guaranty, dated as of September 22, 2016, by Ares Commercial Real Estate Corporation, as guarantor, and Metropolitan Life Insurance Company, as buyer.(21)
|
|
|
*
|
Assignment and Amendment No. 1 to Custodial Agreement, dated November 2, 2016, among ACRC Lender U LLC and ACRC Lender U TRS LLC, as sellers, ACRC Lender U Mezz LLC, as mezzanine subsidiary, UBS Real Estate Securities Inc., as assignor, UBS AG, as assignee, and Wells Fargo Bank, N.A., as Custodian.(31)
|
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
*
|
Assignment and Amendment No. 3 to Master Repurchase Agreement, dated November 2, 2016, among ACRC Lender U LLC and ACRC Lender U TRS LLC, as sellers, ACRC Lender U Mezz LLC, as mezzanine subsidiary, UBS Real Estate Securities, Inc., as assignor, UBS AG, as assignee, and Ares Commercial Real Estate Corporation, as guarantor.(31)
|
|
|
*
|
Assignment and Reaffirmation of Guaranty, dated November 2, 2016, among UBS Real Estate Securities Inc., as assignor, UBS AG, as assignee, and Ares Commercial Real Estate Corporation, as guarantor.(31)
|
|
|
*
|
Amendment No. 3 to Master Repurchase Agreement dated as of December 8, 2016, by and among, ACRC Lender C LLC, Ares Commercial Real Estate Corporation, as Guarantor, and Citibank, N.A., a national banking association, as Buyer.(22)
|
|
|
*
|
Amendment No. 4 to Credit Agreement and Amendment No. 1 to General Continuing Guaranty dated as of December 27, 2016, by and among, by and among ACRC Lender LLC, as borrower, Ares Commercial Real Estate Corporation, as Guarantor and City National Bank, a national banking association, as administrative agent, and the lenders party thereto.(31)
|
|
|
*
|
Reaffirmation and Consent to Amendment No. 4 to Credit Agreement and Amendment No. 1 to General Continuing Guaranty dated as of December 27, 2016, by and among, by and among ACRC Lender LLC, as borrower, Ares Commercial Real Estate Corporation, as Guarantor and City National Bank, a national banking association, as administrative agent, and the lenders party thereto.(31)
|
|
|
*
|
Amendment No. 5 to Credit Agreement dated as of March 2, 2017, by and among ACRC Lender LLC, as borrower, Ares Commercial Real Estate Corporation, as Guarantor and City National Bank, a national banking association, as administrative agent, and the lenders party thereto.(23)
|
|
|
*
|
Indenture dated as of March 2, 2017 among ACRE Commercial Mortgage 2017-FL3 Ltd, as issuer, ACRE Commercial Mortgage 2017-FL3 LLC as co-issuer, Wilmington Trust, National Association, as trustee, Wells Fargo Bank, National Association, as note administrator, paying agent, calculation agent, transfer agent, authentication agent and custodian, and Wells Fargo Bank, National Association, as advancing agent.(23)
|
|
|
*
|
Mortgage Asset Purchase Agreement dated as of March 2, 2017 between ACRC Lender LLC, as seller and ACRE Commercial Mortgage 2017-FL3 Ltd., as issuer.(23)
|
|
|
*
|
Amendment No. 6 to the Credit Agreement dated as of April 19, 2017, by and among, the several banks and other financial institutions and lenders from time to time party hereto, each individually as a lender and, collectively, as the lenders, and City National Bank, as administrative agent to the lenders, and ACRC Lender LLC, as the borrower.(24)
|
|
|
*
|
Second Amended and Restated Master Repurchase and Securities Contract dated as of May 1, 2017, by and among, ACRC Lender W LLC, as existing seller, ACRC Lender W TRS LLC, as new seller, and Wells Fargo Bank, National Association, as buyer.(24)
|
|
|
*
|
Reaffirmation Agreement dated as of May 1, 2017, by Ares Commercial Real Estate Corporation in favor of Wells Fargo Bank, National Association.(24)
|
|
|
*
|
Amendment No. 1 to Amended and Restated Bridge Loan Warehousing Credit and Security Agreement dated as of May 25, 2017, by and among ACRC Lender B LLC, as borrower, the Persons party to the Credit Agreement from time to time as lenders, and Bank of America, N.A., as lender and in its capacity as administrative agent for the Lenders under the Credit Agreement, as administrative agent.(25)
|
|
|
*
|
First Amendment to Master Repurchase and Securities Contract dated as of June 23, 2017, by and among ACRC Lender US LLC, as seller, and U.S. Bank National Association, as buyer, and acknowledged and agreed to by Ares Commercial Real Estate Corporation.(26)
|
|
|
*
|
First Amendment to Master Repurchase Agreement, dated as of August 4, 2017, by and between ACRC Lender ML LLC, as seller, and Metropolitan Life Insurance Company, as buyer.(27)
|
|
|
*
|
Reaffirmation of Guarantor, dated as of August 4, 2017, by Ares Commercial Real Estate Corporation in favor of Metropolitan Life Insurance Company.(27)
|
|
|
*
|
First Supplemental Indenture dated as of August 16, 2017, to the Indenture, dated as of March 2, 2017 among ACRE Commercial Mortgage 2017-FL3 Ltd, as issuer, ACRE Commercial Mortgage 2017-FL3 LLC as co-issuer, Wilmington Trust, National Association, as trustee, Wells Fargo Bank, National Association, as note administrator, paying agent, calculation agent, transfer agent, authentication agent and custodian, and Wells Fargo Bank, National Association, as advancing agent.(28)
|
|
|
*
|
Amendment No. 2 to Amended and Restated Bridge Loan Warehousing Credit and Security Agreement, dated as of October 2, 2017, by and among ACRC Lender B LLC, Bank of America, N.A., as Administrative Agent and Lender and the other Lenders.(29)
|
|
|
*
|
First Amendment to Credit and Guaranty Agreement dated as of December 22, 2017 and is entered into by and among, Wilmington Trust, National Association, as grantor trust trustee, as lender, Cortland Capital Market Services LLC, as the administrative agent and the collateral agent for the lenders, and Ares Commercial Real Estate Corporation, as borrower and ACRC Holdings LLC, ACRC Mezz Holdings LLC, ACRC CP Investor LLC and ACRC Warehouse Holdings LLC, as guarantors.(30)
|
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
*
|
Second Amendment to Master Repurchase and Securities Contract, dated as of March 15, 2018, by and between ACRC Lender US LLC, as seller, and U.S. Bank National Association, as buyer, and acknowledged and agreed to by Ares Commercial Real Estate Corporation.(32)
|
|
|
*
|
Amendment No. 3 to Bridge Loan Warehousing Credit and Security Agreement, dated as of May 24, 2018, by and among ACRC Lender B LLC, Bank of America, N.A., as Administrative Agent and Lender and the other Lenders.(33)
|
|
|
*
|
Amended and Restated Fourth Amendment to Master Repurchase Agreement dated as of December 13, 2018, among ACRC Lender C LLC, as seller, Ares Commercial Real Estate Corporation, as guarantor, and Citibank, N.A., as buyer.(35)
|
|
|
*
|
Second Amended and Restated Substitute Guaranty Agreement, dated as of December 13, 2018, by Ares Commercial Real Estate Corporation in favor of Citibank, N.A.(35)
|
|
|
*
|
Amendment Number One to the Second Amended and Restated Master Repurchase and Securities Contract dated as of December 14, 2018, by and among, ACRC Lender W LLC, as seller, ACRC Lender W TRS LLC, as seller, and Wells Fargo Bank, National Association, as buyer.(36)
|
|
|
|
Subsidiaries of Ares Commercial Real Estate Corporation
|
|
|
|
Consent of Ernst & Young LLP
|
|
|
|
Certification of Chief Executive Officer pursuant to Rule 13a‑14(a) and Rule 15d‑14(a), as adopted pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002
|
|
|
|
Certification of Chief Financial Officer pursuant to Rule 13a‑14(a) and Rule 15d‑14(a), as adopted pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002
|
|
|
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
*
|
Previously filed
|
|
#
|
Denotes a management contract or compensatory plan or arrangement
|
|
(1)
|
Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K (File No. 001-35517), filed on June 29, 2016.
|
|
(2)
|
Incorporated by reference to Exhibit 3.1 to the Company’s Form 10-K (File No. 001-35517), filed on March 1, 2016.
|
|
(3)
|
Incorporated by reference to Exhibit 3.2 to the Company’s Form S‑8 (File No. 333‑181077), filed on May 1, 2012
|
|
(4)
|
Incorporated by reference to Exhibits 10.1, 10.3, 10.4 and 10.5, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on May 4, 2012.
|
|
(5)
|
Incorporated by reference to Exhibit 10.17 to the Company’s Form 10‑K (File No. 001‑35517), filed on March 17, 2014.
|
|
(6)
|
Incorporated by reference to Exhibit 10.4 to the Company’s Registration Statement on Amendment No. 3 to Form S‑11/A (File No. 333‑176841), filed on April 12, 2012.
|
|
(7)
|
Incorporated by reference to Exhibit 10.7 to the Company’s Form 10‑Q (File No. 001‑35517), filed on November 13, 2013.
|
|
(8)
|
Incorporated by reference to Exhibits 10.1, 10.2, 10.3 and 10.4, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on March 14, 2014.
|
|
(9)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on April 15, 2014.
|
|
(10)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on August 18, 2014.
|
|
(11)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on December 12, 2014.
|
|
(12)
|
Incorporated by reference to Exhibits 10.6, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on July 31, 2014.
|
|
(13)
|
Incorporated by reference to Exhibits 10.1, 10.2 and 10.3, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on June 2, 2015.
|
|
(14)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8‑K (File No. 001‑35517), filed on October 26, 2015.
|
|
(15)
|
Incorporated by reference to Exhibits 10.1, 10.2 and 10.3, as applicable, to the Company’s Form 8‑K (File No. 001‑35517), filed on December 14, 2015.
|
|
(16)
|
Incorporated by reference to Exhibits 10.52 and 10.53, as applicable, to the Company’s Form 10-K (File No. 001-35517), filed on March 1, 2016.
|
|
(17)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (file No. 001-35517), filed on June 1, 2016.
|
|
(18)
|
Incorporated by reference to Exhibits 10.4, 10.6, 10.8 and 10.9, as applicable, to the Company’s Form 10-Q (File No. 001-35517), filed on August 4, 2016.
|
|
(19)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on July 19, 2016
|
|
(20)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on August 11, 2016.
|
|
(21)
|
Incorporated by reference to Exhibit 10.11 to the Company’s Form 10-Q (File No. 001-35517), filed on November 3, 2016.
|
|
(22)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on December 12, 2016.
|
|
(23)
|
Incorporated by reference to Exhibits 10.1, 10.2 and 10.3, as applicable, to the Company’s Form 10-Q (File No. 001-35517), filed on May 2, 2017.
|
|
(24)
|
Incorporated by reference to Exhibits 2.2, 10.1, 10.2 and 10.3, as applicable, to the Company’s Form 10-Q (File No. 001-35517), filed on August 3, 2017.
|
|
(25)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on May 30, 2017.
|
|
(26)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on June 28, 2017.
|
|
(27)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8-K (File No. 001-35517), filed on August 9, 2017.
|
|
(28)
|
Incorporated by reference to Exhibit 10.3 to the Company’s Form 10-Q (File No. 001-35517), filed on November 1, 2017.
|
|
(29)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on October 3, 2017.
|
|
(30)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on December 29, 2017.
|
|
(31)
|
Incorporated by reference to Exhibits 10.38, 10.39, 10.40, 10.42 and 10.43, as applicable, to the Company’s Form 10-K (File No. 001-35517), filed on March 1, 2018.
|
|
(32)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 10-Q (File No. 001-35517), filed on May 1, 2018.
|
|
(33)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on May 30, 2018.
|
|
(34)
|
Incorporated by reference to Exhibits 10.1 and 10.3, as applicable, to the Company’s Form S-8 (File No. 333-225891), filed on June 26, 2018.
|
|
(35)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8-K (File No. 001-35517), filed on December 14, 2018.
|
|
(36)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on December 20, 2018.
|
|
|
As of December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
ASSETS
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
11,089
|
|
|
$
|
28,343
|
|
|
Restricted cash
|
379
|
|
|
379
|
|
||
|
Loans held for investment ($289,576 and $341,158 related to consolidated VIEs, respectively)
|
1,524,873
|
|
|
1,726,283
|
|
||
|
Other assets ($843 and $945 of interest receivable related to consolidated VIEs, respectively; $51,582 of other receivables related to consolidated VIEs as of December 31, 2018)
|
66,983
|
|
|
15,214
|
|
||
|
Total assets
|
$
|
1,603,324
|
|
|
$
|
1,770,219
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
||||
|
LIABILITIES
|
|
|
|
||||
|
Secured funding agreements
|
$
|
777,974
|
|
|
$
|
957,960
|
|
|
Secured term loan
|
108,345
|
|
|
107,595
|
|
||
|
Collateralized loan obligation securitization debt (consolidated VIE)
|
270,737
|
|
|
271,211
|
|
||
|
Due to affiliate
|
3,163
|
|
|
2,628
|
|
||
|
Dividends payable
|
8,914
|
|
|
7,722
|
|
||
|
Other liabilities ($541 and $414 of interest payable related to consolidated VIEs, respectively)
|
8,604
|
|
|
3,933
|
|
||
|
Total liabilities
|
1,177,737
|
|
|
1,351,049
|
|
||
|
Commitments and contingencies (Note 5)
|
|
|
|
|
|
||
|
STOCKHOLDERS' EQUITY
|
|
|
|
||||
|
Common stock, par value $0.01 per share, 450,000,000 shares authorized at December 31, 2018 and 2017, and 28,755,665 and 28,598,916 shares issued and outstanding at December 31, 2018 and 2017, respectively
|
283
|
|
|
283
|
|
||
|
Additional paid-in capital
|
421,739
|
|
|
420,637
|
|
||
|
Accumulated earnings (deficit)
|
3,565
|
|
|
(1,750
|
)
|
||
|
Total stockholders' equity
|
425,587
|
|
|
419,170
|
|
||
|
Total liabilities and stockholders' equity
|
$
|
1,603,324
|
|
|
$
|
1,770,219
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net interest margin:
|
|
|
|
|
|
||||||
|
Interest income from loans held for investment
|
$
|
118,284
|
|
|
$
|
97,541
|
|
|
$
|
81,963
|
|
|
Interest expense
|
(63,002
|
)
|
|
(51,193
|
)
|
|
(36,856
|
)
|
|||
|
Net interest margin
|
55,282
|
|
|
46,348
|
|
|
45,107
|
|
|||
|
Expenses:
|
|
|
|
|
|
|
|||||
|
Management and incentive fees to affiliate
|
7,418
|
|
|
6,569
|
|
|
5,956
|
|
|||
|
Professional fees
|
1,945
|
|
|
1,674
|
|
|
2,228
|
|
|||
|
General and administrative expenses
|
3,307
|
|
|
2,828
|
|
|
2,801
|
|
|||
|
General and administrative expenses reimbursed to affiliate
|
3,570
|
|
|
3,899
|
|
|
3,441
|
|
|||
|
Total expenses
|
16,240
|
|
|
14,970
|
|
|
14,426
|
|
|||
|
Early extinguishment of debt costs
|
—
|
|
|
(768
|
)
|
|
—
|
|
|||
|
Income from continuing operations before income taxes
|
39,042
|
|
|
30,610
|
|
|
30,681
|
|
|||
|
Income tax expense, including excise tax
|
446
|
|
|
178
|
|
|
230
|
|
|||
|
Net income from continuing operations
|
38,596
|
|
|
30,432
|
|
|
30,451
|
|
|||
|
Net income from operations of discontinued operations, net of income taxes
|
—
|
|
|
—
|
|
|
4,221
|
|
|||
|
Gain on sale of discontinued operations
|
—
|
|
|
—
|
|
|
10,196
|
|
|||
|
Net income attributable to ACRE
|
38,596
|
|
|
30,432
|
|
|
44,868
|
|
|||
|
Less: Net income attributable to non-controlling interests
|
—
|
|
|
(25
|
)
|
|
(4,532
|
)
|
|||
|
Net income attributable to common stockholders
|
$
|
38,596
|
|
|
$
|
30,407
|
|
|
$
|
40,336
|
|
|
Basic earnings per common share:
|
|
|
|
|
|
||||||
|
Continuing operations
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
Discontinued operations
|
—
|
|
|
—
|
|
|
0.51
|
|
|||
|
Net income
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
1.42
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
||||||
|
Continuing operations
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
Discontinued operations
|
—
|
|
|
—
|
|
|
0.51
|
|
|||
|
Net income
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
1.41
|
|
|
Weighted average number of common shares outstanding:
|
|
|
|
|
|
||||||
|
Basic weighted average shares of common stock outstanding
|
28,529,439
|
|
|
28,478,237
|
|
|
28,461,853
|
|
|||
|
Diluted weighted average shares of common stock outstanding
|
28,656,660
|
|
|
28,550,945
|
|
|
28,523,306
|
|
|||
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated
Earnings (Deficit)
|
|
Total Stockholders’ Equity
|
|
Non-Controlling
Interests
|
|
Total
Equity
|
|||||||||||||||
|
|
Shares
|
|
Amount
|
|||||||||||||||||||||||
|
Balance at December 31, 2015
|
28,609,650
|
|
|
$
|
284
|
|
|
$
|
421,179
|
|
|
$
|
(11,992
|
)
|
|
$
|
409,471
|
|
|
$
|
47,017
|
|
|
$
|
456,488
|
|
|
Stock‑based compensation
|
3,022
|
|
|
—
|
|
|
312
|
|
|
—
|
|
|
312
|
|
|
—
|
|
|
312
|
|
||||||
|
Repurchase and retirement of common stock
|
(129,916
|
)
|
|
(1
|
)
|
|
(1,435
|
)
|
|
—
|
|
|
(1,436
|
)
|
|
—
|
|
|
(1,436
|
)
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
40,336
|
|
|
40,336
|
|
|
4,532
|
|
|
44,868
|
|
||||||
|
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(29,654
|
)
|
|
(29,654
|
)
|
|
—
|
|
|
(29,654
|
)
|
||||||
|
Contributions from non‑controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|
11
|
|
||||||
|
Distributions to non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(40,916
|
)
|
|
(40,916
|
)
|
||||||
|
Balance at December 31, 2016
|
28,482,756
|
|
|
$
|
283
|
|
|
$
|
420,056
|
|
|
$
|
(1,310
|
)
|
|
$
|
419,029
|
|
|
$
|
10,644
|
|
|
$
|
429,673
|
|
|
Stock‑based compensation
|
116,160
|
|
|
—
|
|
|
581
|
|
|
—
|
|
|
581
|
|
|
—
|
|
|
581
|
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
30,407
|
|
|
30,407
|
|
|
25
|
|
|
30,432
|
|
||||||
|
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(30,847
|
)
|
|
(30,847
|
)
|
|
—
|
|
|
(30,847
|
)
|
||||||
|
Contributions from non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12
|
|
|
12
|
|
||||||
|
Distributions to non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(10,681
|
)
|
|
(10,681
|
)
|
||||||
|
Balance at December 31, 2017
|
28,598,916
|
|
|
$
|
283
|
|
|
$
|
420,637
|
|
|
$
|
(1,750
|
)
|
|
$
|
419,170
|
|
|
$
|
—
|
|
|
$
|
419,170
|
|
|
Stock-based compensation
|
156,749
|
|
|
—
|
|
|
1,102
|
|
|
—
|
|
|
1,102
|
|
|
—
|
|
|
1,102
|
|
||||||
|
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
38,596
|
|
|
38,596
|
|
|
—
|
|
|
38,596
|
|
||||||
|
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(33,281
|
)
|
|
(33,281
|
)
|
|
—
|
|
|
(33,281
|
)
|
||||||
|
Balance at December 31, 2018
|
28,755,665
|
|
|
$
|
283
|
|
|
$
|
421,739
|
|
|
$
|
3,565
|
|
|
$
|
425,587
|
|
|
$
|
—
|
|
|
$
|
425,587
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Operating activities:
|
|
|
|
|
|
||||||
|
Net income
|
$
|
38,596
|
|
|
$
|
30,432
|
|
|
$
|
44,868
|
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities (inclusive of amounts related to discontinued operations):
|
|
|
|
|
|
||||||
|
Amortization of deferred financing costs
|
5,720
|
|
|
7,608
|
|
|
6,439
|
|
|||
|
Change in mortgage banking activities
|
—
|
|
|
—
|
|
|
(10,386
|
)
|
|||
|
Change in fair value of mortgage servicing rights
|
—
|
|
|
—
|
|
|
6,457
|
|
|||
|
Accretion of deferred loan origination fees and costs
|
(6,949
|
)
|
|
(6,578
|
)
|
|
(5,924
|
)
|
|||
|
Provision for loss sharing
|
—
|
|
|
—
|
|
|
(146
|
)
|
|||
|
Cash paid to settle loss sharing obligations
|
—
|
|
|
—
|
|
|
(681
|
)
|
|||
|
Originations of mortgage loans held for sale
|
—
|
|
|
—
|
|
|
(639,413
|
)
|
|||
|
Sale of mortgage loans held for sale to third parties
|
—
|
|
|
—
|
|
|
571,714
|
|
|||
|
Stock-based compensation
|
1,102
|
|
|
581
|
|
|
312
|
|
|||
|
Early extinguishment of debt costs
|
—
|
|
|
768
|
|
|
—
|
|
|||
|
Gain on sale of discontinued operations
|
—
|
|
|
—
|
|
|
(10,196
|
)
|
|||
|
Depreciation expense
|
—
|
|
|
—
|
|
|
167
|
|
|||
|
Deferred tax expense
|
—
|
|
|
—
|
|
|
2,049
|
|
|||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
||||||
|
Other assets
|
198
|
|
|
(2,530
|
)
|
|
40,016
|
|
|||
|
Due to affiliate
|
535
|
|
|
(71
|
)
|
|
380
|
|
|||
|
Other liabilities
|
16
|
|
|
1,066
|
|
|
(10,146
|
)
|
|||
|
Net cash provided by (used in) operating activities
|
39,218
|
|
|
31,276
|
|
|
(4,490
|
)
|
|||
|
Investing activities:
|
|
|
|
|
|
|
|||||
|
Issuance of and fundings on loans held for investment
|
(543,077
|
)
|
|
(900,289
|
)
|
|
(861,444
|
)
|
|||
|
Principal repayment of loans held for investment
|
695,183
|
|
|
411,298
|
|
|
721,684
|
|
|||
|
Proceeds from sale of mortgage loans held for sale
|
—
|
|
|
73,900
|
|
|
—
|
|
|||
|
Receipt of origination fees
|
5,818
|
|
|
9,323
|
|
|
6,813
|
|
|||
|
Proceeds from sale of discontinued operations, net of cash and restricted cash sold
|
—
|
|
|
—
|
|
|
73,004
|
|
|||
|
Purchases of other assets
|
—
|
|
|
—
|
|
|
(354
|
)
|
|||
|
Net cash provided by (used in) investing activities
|
157,924
|
|
|
(405,768
|
)
|
|
(60,297
|
)
|
|||
|
Financing activities:
|
|
|
|
|
|
||||||
|
Proceeds from secured funding agreements
|
642,241
|
|
|
923,882
|
|
|
1,288,698
|
|
|||
|
Repayments of secured funding agreements
|
(822,227
|
)
|
|
(746,635
|
)
|
|
(1,030,760
|
)
|
|||
|
Payment of secured funding costs
|
(2,322
|
)
|
|
(8,405
|
)
|
|
(5,563
|
)
|
|||
|
Proceeds from issuance of debt of consolidated VIEs
|
—
|
|
|
272,927
|
|
|
—
|
|
|||
|
Repayments of debt of consolidated VIEs
|
—
|
|
|
—
|
|
|
(255,275
|
)
|
|||
|
Proceeds from warehouse lines of credit
|
—
|
|
|
—
|
|
|
863,382
|
|
|||
|
Repayments of warehouse lines of credit
|
—
|
|
|
—
|
|
|
(795,684
|
)
|
|||
|
Proceeds from secured term loan
|
—
|
|
|
—
|
|
|
80,000
|
|
|||
|
Repayments of secured term loan
|
—
|
|
|
(45,000
|
)
|
|
—
|
|
|||
|
Repurchase of common stock
|
—
|
|
|
—
|
|
|
(1,436
|
)
|
|||
|
Dividends paid
|
(32,088
|
)
|
|
(30,531
|
)
|
|
(29,400
|
)
|
|||
|
Contributions from non-controlling interests
|
—
|
|
|
12
|
|
|
11
|
|
|||
|
Distributions to non-controlling interests
|
—
|
|
|
(10,681
|
)
|
|
(40,916
|
)
|
|||
|
Net cash provided by (used in) financing activities
|
(214,396
|
)
|
|
355,569
|
|
|
73,057
|
|
|||
|
Change in cash, cash equivalents and restricted cash
|
(17,254
|
)
|
|
(18,923
|
)
|
|
8,270
|
|
|||
|
Cash, cash equivalents and restricted cash of continuing operations, beginning of period
|
28,722
|
|
|
47,645
|
|
|
18,149
|
|
|||
|
Cash, cash equivalents and restricted cash of discontinued operations, beginning of period
|
—
|
|
|
—
|
|
|
21,226
|
|
|||
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
11,468
|
|
|
$
|
28,722
|
|
|
$
|
47,645
|
|
|
Cash, cash equivalents and restricted cash of continuing operations, end of period
|
$
|
11,468
|
|
|
$
|
28,722
|
|
|
$
|
47,645
|
|
|
Cash, cash equivalents and restricted cash of discontinued operations, end of period
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Supplemental Information:
|
|
|
|
|
|
||||||
|
Interest paid during the period
|
$
|
56,719
|
|
|
$
|
41,891
|
|
|
$
|
30,066
|
|
|
Income taxes paid during the period
|
$
|
360
|
|
|
$
|
240
|
|
|
$
|
—
|
|
|
Supplemental disclosure of noncash investing and financing activities:
|
|
|
|
|
|
||||||
|
Dividends declared, but not yet paid
|
$
|
8,914
|
|
|
$
|
7,722
|
|
|
$
|
7,406
|
|
|
Other receivables related to consolidated VIEs
|
$
|
51,582
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Cash and cash equivalents
|
$
|
11,089
|
|
|
$
|
28,343
|
|
|
$
|
47,270
|
|
|
Restricted cash
|
379
|
|
|
379
|
|
|
375
|
|
|||
|
Total cash, cash equivalents and restricted cash shown in the Company's consolidated statements of cash flows
|
$
|
11,468
|
|
|
$
|
28,722
|
|
|
$
|
47,645
|
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Interest income from loans held for investment, excluding non-controlling interests
|
|
$
|
118,284
|
|
|
$
|
97,506
|
|
|
$
|
77,424
|
|
|
Interest income from non-controlling interest investment held by third parties
|
|
—
|
|
|
35
|
|
|
4,539
|
|
|||
|
Interest income from loans held for investment
|
|
$
|
118,284
|
|
|
$
|
97,541
|
|
|
$
|
81,963
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Secured funding agreements and securitizations debt
|
$
|
54,473
|
|
|
$
|
37,602
|
|
|
$
|
27,856
|
|
|
Secured term loan
|
8,529
|
|
|
13,591
|
|
|
9,000
|
|
|||
|
Interest expense
|
$
|
63,002
|
|
|
$
|
51,193
|
|
|
$
|
36,856
|
|
|
|
As of December 31, 2018
|
||||||||||||||
|
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Minimum Loan Borrowing Spread (2)
|
|
Weighted Average Unleveraged Effective Yield (3)
|
|
Weighted Average Remaining Life (Years)
|
||||||
|
Senior mortgage loans
|
$
|
1,489,708
|
|
|
$
|
1,498,530
|
|
|
5.2
|
%
|
|
7.0
|
%
|
|
1.7
|
|
Subordinated debt and preferred equity investments
|
35,165
|
|
|
36,213
|
|
|
12.7
|
%
|
|
14.9
|
%
|
|
4.3
|
||
|
Total loans held for investment portfolio
|
$
|
1,524,873
|
|
|
$
|
1,534,743
|
|
|
5.4
|
%
|
|
7.1
|
%
|
|
1.8
|
|
|
As of December 31, 2017
|
||||||||||||||
|
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Minimum Loan Borrowing Spread (2)
|
|
Weighted Average Unleveraged Effective Yield (3)
|
|
Weighted Average Remaining Life (Years)
|
||||||
|
Senior mortgage loans
|
$
|
1,674,169
|
|
|
$
|
1,684,439
|
|
|
4.8
|
%
|
|
6.2
|
%
|
|
1.9
|
|
Subordinated debt and preferred equity investments
|
52,114
|
|
|
52,847
|
|
|
9.5
|
%
|
|
10.8
|
%
|
|
3.4
|
||
|
Total loans held for investment portfolio
|
$
|
1,726,283
|
|
|
$
|
1,737,286
|
|
|
5.0
|
%
|
|
6.3
|
%
|
|
2.0
|
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
|
|
(2)
|
Minimum Loan Borrowing Spread is equal to (a) for floating rate loans, the margin above the applicable index rate (e.g., LIBOR) plus floors, if any, on such applicable index rates, and (b) for fixed rate loans, the applicable interest rate.
|
|
(3)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes
no
dispositions, early prepayments or defaults. The total Weighted Average Unleveraged Effective Yield
|
|
Loan Type
|
|
Location
|
|
Outstanding Principal (1)
|
|
Carrying Amount (1)
|
|
Interest Rate
|
|
Unleveraged Effective Yield (2)
|
|
Maturity Date (3)
|
|
Payment Terms (4)
|
|
|
Senior Mortgage Loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Multifamily
|
|
FL
|
|
$89.7
|
|
$89.5
|
|
L+4.75%
|
|
7.8%
|
|
Sep 2019
|
|
I/O
|
|
|
Hotel
|
|
Diversified
|
|
68.0
|
|
67.4
|
|
L+3.60%
|
|
6.6%
|
|
Sep 2021
|
|
I/O
|
|
|
Office
|
|
TX
|
|
67.2
|
|
66.8
|
|
L+3.60%
|
|
6.6%
|
|
July 2020
|
|
I/O
|
|
|
Hotel
|
|
OR/WA
|
|
64.1
|
|
63.6
|
|
L+3.45%
|
|
6.5%
|
|
May 2021
|
|
I/O
|
|
|
Multifamily
|
|
UT
|
|
63.5
|
|
63.2
|
|
L+3.25%
|
|
6.0%
|
|
Dec 2020
|
|
I/O
|
|
|
Office
|
|
IL
|
|
63.2
|
|
63.1
|
|
L+3.99%
|
|
6.9%
|
|
Aug 2019
|
|
I/O
|
|
|
Office
|
|
IL
|
|
61.2
|
|
60.8
|
|
L+3.75%
|
|
6.8%
|
|
Dec 2020
|
|
I/O
|
|
|
Office
|
|
NJ
|
|
54.5
|
|
54.2
|
|
L+4.65%
|
|
7.7%
|
|
July 2020
|
|
I/O
|
|
|
Office
|
|
IL
|
|
54.1
|
|
53.8
|
|
L+3.95%
|
|
6.8%
|
|
June 2021
|
|
I/O
|
|
|
Industrial
|
|
MN
|
|
52.0
|
|
51.7
|
|
L+3.15%
|
|
6.1%
|
|
Dec 2020
|
|
I/O
|
|
|
Mixed-use
|
|
CA
|
|
49.0
|
|
48.7
|
|
L+4.00%
|
|
6.9%
|
|
Apr 2021
|
|
I/O
|
|
|
Multifamily
|
|
FL
|
|
45.4
|
|
45.3
|
|
L+4.75%
|
|
7.8%
|
|
Sep 2019
|
|
I/O
|
|
|
Multifamily
|
|
TX
|
|
42.7
|
|
42.5
|
|
L+3.30%
|
|
6.2%
|
|
Dec 2020
|
|
I/O
|
|
|
Student Housing
|
|
CA
|
|
41.8
|
|
41.5
|
|
L+3.95%
|
|
7.0%
|
|
July 2020
|
|
I/O
|
|
|
Multifamily
|
|
FL
|
|
41.2
|
|
40.8
|
|
L+2.60%
|
|
5.7%
|
|
Jan 2022
|
|
I/O
|
|
|
Student Housing
|
|
TX
|
|
41.0
|
|
40.7
|
|
L+4.75%
|
|
7.8%
|
|
Jan 2021
|
|
I/O
|
|
|
Hotel
|
|
CA
|
|
40.0
|
|
39.7
|
|
L+4.12%
|
|
7.0%
|
|
Jan 2021
|
|
I/O
|
|
|
Multifamily
|
|
SC
|
|
38.9
|
|
38.7
|
|
L+3.36%
|
|
6.3%
|
|
May 2021
|
|
I/O
|
|
|
Student Housing
|
|
NC
|
|
38.7
|
|
38.7
|
|
L+4.00%
|
|
7.5%
|
|
Feb 2019
|
|
I/O
|
|
|
Hotel
|
|
NY
|
|
38.6
|
|
38.6
|
|
L+4.75%
|
|
7.3%
|
|
Dec 2018
|
(5)
|
I/O
|
|
|
Multifamily
|
|
IL
|
|
37.0
|
|
36.6
|
|
L+3.50%
|
|
6.7%
|
|
Nov 2020
|
|
I/O
|
|
|
Hotel
|
|
MI
|
|
35.2
|
|
35.2
|
|
L+4.15%
|
|
6.7%
|
|
July 2019
|
(6)
|
I/O
|
|
|
Hotel
|
|
MN
|
|
31.5
|
|
31.2
|
|
L+3.55%
|
|
6.4%
|
|
Aug 2021
|
|
I/O
|
|
|
Multifamily
|
|
NY
|
|
30.1
|
|
30.0
|
|
L+3.20%
|
|
6.1%
|
|
Dec 2020
|
|
I/O
|
|
|
Multifamily
|
|
PA
|
|
29.4
|
|
29.1
|
|
L+3.00%
|
|
6.1%
|
|
Dec 2021
|
|
I/O
|
|
|
Office
|
|
CO
|
|
27.6
|
|
27.3
|
|
L+4.15%
|
|
7.1%
|
|
June 2021
|
|
I/O
|
|
|
Multifamily
|
|
TX
|
|
27.5
|
|
27.4
|
|
L+3.20%
|
|
6.2%
|
|
Oct 2020
|
|
I/O
|
|
|
Multifamily
|
|
CA
|
|
26.8
|
|
26.7
|
|
L+3.85%
|
|
6.8%
|
|
July 2020
|
|
I/O
|
|
|
Student Housing
|
|
AL
|
|
24.1
|
|
24.0
|
|
L+4.45%
|
|
7.5%
|
|
Feb 2020
|
|
I/O
|
|
|
Student Housing
|
|
TX
|
|
24.0
|
|
23.8
|
|
L+4.10%
|
|
7.1%
|
|
Jan 2021
|
|
I/O
|
|
|
Hotel
|
|
IL
|
|
21.4
|
|
21.2
|
|
L+4.40%
|
|
7.5%
|
|
May 2021
|
|
I/O
|
|
|
Multifamily
|
|
CA
|
|
19.8
|
|
19.6
|
|
L+3.30%
|
|
6.2%
|
|
Feb 2021
|
|
I/O
|
|
|
Office
|
|
PA
|
|
19.6
|
|
19.5
|
|
L+4.70%
|
|
7.7%
|
|
Mar 2020
|
|
I/O
|
|
|
Multifamily
|
|
FL
|
|
19.2
|
|
19.1
|
|
L+4.00%
|
|
6.9%
|
|
Nov 2020
|
|
I/O
|
|
|
Office
|
|
FL
|
|
18.4
|
|
18.3
|
|
L+4.30%
|
|
7.4%
|
|
Apr 2020
|
|
I/O
|
|
|
Residential Condominium
|
|
FL
|
|
17.5
|
|
17.4
|
|
L+8.00%
|
|
11.9%
|
|
Apr 2020
|
|
I/O
|
|
|
Office
|
|
CA
|
|
17.5
|
|
17.3
|
|
L+3.40%
|
|
6.5%
|
|
Nov 2021
|
|
I/O
|
|
|
Residential
|
|
CA
|
|
9.1
|
|
8.8
|
|
12.00%
|
|
14.8%
|
|
Feb 2020
|
|
I/O
|
|
|
Office
|
|
NC
|
|
8.0
|
|
7.9
|
|
L+4.00%
|
|
7.1%
|
|
Nov 2022
|
|
I/O
|
|
|
Subordinated Debt and Preferred Equity Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Office
|
|
NJ
|
|
17.0
|
|
16.4
|
|
12.00%
|
|
12.8%
|
|
Jan 2026
|
|
I/O
|
(7)
|
|
Residential Condominium
|
|
NY
|
|
10.8
|
|
10.6
|
|
L+14.00%
|
|
17.5%
|
|
May 2021
|
|
I/O
|
|
|
Residential Condominium
|
|
HI
|
|
4.7
|
|
4.7
|
|
14.00%
|
|
19.1%
|
|
Apr 2019
|
|
I/O
|
|
|
Office
|
|
CA
|
|
2.7
|
|
2.7
|
|
L+8.25%
|
|
10.9%
|
|
Nov 2021
|
|
I/O
|
|
|
Mixed-use
|
|
IL
|
|
1.0
|
|
0.8
|
|
L+12.25%
|
|
15.7%
|
|
Nov 2021
|
|
I/O
|
|
|
Total/Weighted Average
|
|
|
|
$1,534.7
|
|
$1,524.9
|
|
|
|
7.1%
|
|
|
|
|
|
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. For the loans held for investment that represent co-investments with other investment vehicles managed by Ares Management (see Note 10 included in these consolidated financial statements for additional information on co-investments), only the portion of Carrying Amount and Outstanding Principal held by the Company is reflected.
|
|
(2)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premiums or discounts) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR as of
December 31, 2018
or the LIBOR floor, as applicable. The total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of
December 31, 2018
as weighted by the outstanding principal balance of each loan.
|
|
(3)
|
Certain loans are subject to contractual extension options that generally vary between
one
and
two
12
-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.
|
|
(4)
|
I/O = interest only, P/I = principal and interest.
|
|
(5)
|
As of December 31, 2018, the
$38.6 million
senior mortgage loan, which is collateralized by a hotel property located in New York, is in maturity default. See below in this Note 3 included in these consolidated financial statements for further discussion of this loan.
|
|
(6)
|
In June 2018, the borrower exercised a one-year extension option in accordance with the loan agreement, which extended the maturity date on the senior Michigan loan to July 2019.
|
|
(7)
|
In February 2021, amortization will begin on the subordinated New Jersey loan, which had an outstanding principal balance of
$17.0
million as of
December 31, 2018
. The remainder of the loans in the Company’s portfolio are non-amortizing through their primary terms.
|
|
Balance at December 31, 2016
|
$
|
1,313,937
|
|
|
Initial funding
|
878,834
|
|
|
|
Origination fees and discounts, net of costs
|
(9,323
|
)
|
|
|
Additional funding
|
21,455
|
|
|
|
Amortizing payments
|
(509
|
)
|
|
|
Loan payoffs
|
(410,789
|
)
|
|
|
Loans sold to third parties (1)
|
(73,900
|
)
|
|
|
Origination fee accretion
|
6,578
|
|
|
|
Balance at December 31, 2017
|
$
|
1,726,283
|
|
|
Initial funding
|
510,529
|
|
|
|
Origination fees and discounts, net of costs
|
(5,816
|
)
|
|
|
Additional funding
|
33,693
|
|
|
|
Amortizing payments
|
(645
|
)
|
|
|
Loan payoffs
|
(746,120
|
)
|
|
|
Origination fee accretion
|
6,949
|
|
|
|
Balance at December 31, 2018
|
$
|
1,524,873
|
|
|
(1)
|
In December 2017, the Company sold a senior mortgage loan and a B-Note mortgage loan with outstanding principal of
$63.9 million
and
$10.0 million
, respectively, which were both collateralized by an office property located in Texas, to a third party. Both loans were previously classified as held for investment and were sold in order to rebalance and optimize the Company’s loan portfolio. No gain or loss was recognized on the sale.
|
|
|
As of December 31,
|
|||||||||||||||
|
|
2018
|
|
2017
|
|
||||||||||||
|
|
Outstanding Balance
|
|
Total
Commitment |
|
Outstanding Balance
|
|
Total
Commitment |
|
||||||||
|
Wells Fargo Facility
|
$
|
274,071
|
|
|
$
|
500,000
|
|
|
$
|
407,853
|
|
|
$
|
500,000
|
|
|
|
Citibank Facility
|
184,003
|
|
|
325,000
|
|
(1)
|
175,651
|
|
|
250,000
|
|
(1)
|
||||
|
BAML Facility
|
36,280
|
|
|
125,000
|
|
|
78,320
|
|
|
125,000
|
|
|
||||
|
CNB Facility
|
—
|
|
|
50,000
|
|
|
—
|
|
|
50,000
|
|
|
||||
|
MetLife Facility
|
135,145
|
|
|
180,000
|
|
|
101,131
|
|
|
180,000
|
|
|
||||
|
UBS Facility
|
—
|
|
|
—
|
|
(2)
|
34,000
|
|
|
140,000
|
|
|
||||
|
U.S. Bank Facility
|
148,475
|
|
|
185,989
|
|
|
161,005
|
|
|
185,989
|
|
|
||||
|
Secured Term Loan
|
110,000
|
|
|
110,000
|
|
|
110,000
|
|
|
110,000
|
|
|
||||
|
Total
|
$
|
887,974
|
|
|
$
|
1,475,989
|
|
|
$
|
1,067,960
|
|
|
$
|
1,540,989
|
|
|
|
(1)
|
As of December 31, 2017, the Citibank Facility (as defined below) had an accordion feature that provided for an increase in the
$250.0 million
commitment amount with respect to approved assets, as determined by Citibank, N.A. in its sole discretion. In December 2018, the Company amended the Citibank Facility to, among other things, increase the facility’s commitment amount from
$250.0 million
to
$325.0 million
and remove the accordion feature.
|
|
(2)
|
In October 2018, the UBS Facility (as defined below) matured. The UBS Facility had been repaid in full and its term was not extended.
|
|
|
Wells Fargo
Facility |
|
Citibank
Facility |
|
BAML Facility
|
|
CNB
Facility
|
|
MetLife Facility
|
|
U.S. Bank Facility
|
|
Secured Term Loan
|
|
Total
|
||||||||||||||||
|
2019
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
36,280
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
36,280
|
|
|
2020
|
274,071
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
135,145
|
|
|
148,475
|
|
|
110,000
|
|
|
667,691
|
|
||||||||
|
2021
|
—
|
|
|
184,003
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
184,003
|
|
||||||||
|
2022
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
2023
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
Thereafter
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
|
$
|
274,071
|
|
|
$
|
184,003
|
|
|
$
|
36,280
|
|
|
$
|
—
|
|
|
$
|
135,145
|
|
|
$
|
148,475
|
|
|
$
|
110,000
|
|
|
$
|
887,974
|
|
|
|
As of December 31,
|
||||||
|
|
2018
|
|
2017
|
||||
|
Total commitments
|
$
|
1,677,615
|
|
|
$
|
1,847,534
|
|
|
Less: funded commitments
|
(1,534,743
|
)
|
|
(1,737,286
|
)
|
||
|
Total unfunded commitments
|
$
|
142,872
|
|
|
$
|
110,248
|
|
|
Grant Date
|
|
Vesting Start Date
|
|
Shares Granted
|
|
May 1, 2012
|
|
July 1, 2012
|
|
35,135
|
|
June 18, 2012
|
|
July 1, 2012
|
|
7,027
|
|
July 9, 2012
|
|
October 1, 2012
|
|
25,000
|
|
June 26, 2013
|
|
July 1, 2013
|
|
22,526
|
|
November 25, 2013
|
|
November 25, 2016
|
|
30,381
|
|
January 31, 2014
|
|
August 31, 2015
|
|
48,273
|
|
February 26, 2014
|
|
February 26, 2014
|
|
12,030
|
|
February 27, 2014
|
|
August 27, 2014
|
|
22,354
|
|
June 24, 2014
|
|
June 24, 2014
|
|
17,658
|
|
June 24, 2015
|
|
July 1, 2015
|
|
25,555
|
|
April 25, 2016
|
|
July 1, 2016
|
|
10,000
|
|
June 27, 2016
|
|
July 1, 2016
|
|
24,680
|
|
April 25, 2017
|
|
April 25, 2018
|
|
81,710
|
|
June 7, 2017
|
|
July 1, 2017
|
|
18,224
|
|
October 17, 2017
|
|
January 2, 2018
|
|
7,278
|
|
December 15, 2017
|
|
January 2, 2018
|
|
8,948
|
|
May 14, 2018
|
|
July 2, 2018
|
|
31,766
|
|
June 26, 2018
|
|
July 1, 2019
|
|
67,918
|
|
December 14, 2018
|
|
March 31, 2019
|
|
57,065
|
|
Total
|
|
|
|
553,528
|
|
|
Restricted Stock Grants—Directors
|
|
Restricted Stock Grants—Officers and Employees of the Manager
|
|
Total
|
|||
|
Balance at December 31, 2017
|
21,394
|
|
|
90,658
|
|
|
112,052
|
|
|
Granted
|
31,766
|
|
|
124,983
|
|
|
156,749
|
|
|
Vested
|
(30,606
|
)
|
|
(36,185
|
)
|
|
(66,791
|
)
|
|
Forfeited
|
—
|
|
|
—
|
|
|
—
|
|
|
Balance at December 31, 2018
|
22,554
|
|
|
179,456
|
|
|
202,010
|
|
|
|
Restricted Stock Grants—Directors
|
|
Restricted Stock Grants—Officers and Employees of the Manager
|
|
Total
|
|||
|
2019
|
18,384
|
|
|
62,303
|
|
|
80,687
|
|
|
2020
|
3,336
|
|
|
65,313
|
|
|
68,649
|
|
|
2021
|
834
|
|
|
38,072
|
|
|
38,906
|
|
|
2022
|
—
|
|
|
13,768
|
|
|
13,768
|
|
|
2023
|
—
|
|
|
—
|
|
|
—
|
|
|
Total
|
22,554
|
|
|
179,456
|
|
|
202,010
|
|
|
|
For the years ended December 31,
|
||||||||||||||||||||||||||||||||||||||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||||||||||||||||||||||||||||||||||||||
|
|
Restricted Stock Grants
|
|
Restricted Stock Grants
|
|
Restricted Stock Grants
|
||||||||||||||||||||||||||||||||||||||||||
|
|
Directors
|
|
Officers and Employees of the Manager
|
|
Employees
|
|
Total
|
|
Directors
|
|
Officers and Employees of the Manager
|
|
Employees
|
|
Total
|
|
Directors
|
|
Officers and Employees of the Manager
|
|
Employees
|
|
Total
|
||||||||||||||||||||||||
|
Compensation expense (1)
|
$
|
427
|
|
|
$
|
675
|
|
|
$
|
—
|
|
|
$
|
1,102
|
|
|
$
|
317
|
|
|
$
|
264
|
|
|
$
|
—
|
|
|
$
|
581
|
|
|
$
|
355
|
|
|
$
|
53
|
|
|
$
|
(96
|
)
|
|
$
|
312
|
|
|
Total fair value of shares vested (2)
|
405
|
|
|
449
|
|
|
—
|
|
|
854
|
|
|
347
|
|
|
—
|
|
|
—
|
|
|
347
|
|
|
342
|
|
|
54
|
|
|
383
|
|
|
779
|
|
||||||||||||
|
Weighted average grant date fair value
|
427
|
|
|
1,759
|
|
|
—
|
|
|
2,186
|
|
|
338
|
|
|
1,254
|
|
|
—
|
|
|
1,592
|
|
|
412
|
|
|
—
|
|
|
—
|
|
|
412
|
|
||||||||||||
|
(1)
|
Compensation expense for ACRE Capital employees is included within compensation and benefits expense for the year ended December 31, 2016 in the reconciliation of net income from operations of discontinued operations, net of income taxes. See Note
13
included in these consolidated financial statements for more information.
|
|
(2)
|
Based on the closing price of the Company’s common stock on the NYSE on each vesting date.
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net income from continuing operations, less non-controlling interests
|
$
|
38,596
|
|
|
$
|
30,407
|
|
|
$
|
25,919
|
|
|
Net income from discontinued operations, including gain on sale of discontinued operations
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
14,417
|
|
|
Divided by:
|
|
|
|
|
|
|
|||||
|
Basic weighted average shares of common stock outstanding:
|
28,529,439
|
|
|
28,478,237
|
|
|
28,461,853
|
|
|||
|
Weighted average non-vested restricted stock
|
127,221
|
|
|
72,708
|
|
|
61,453
|
|
|||
|
Diluted weighted average shares of common stock outstanding:
|
28,656,660
|
|
|
28,550,945
|
|
|
28,523,306
|
|
|||
|
Basic earnings per common share:
|
|
|
|
|
|
|
|||||
|
Continuing operations
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
Discontinued operations
|
—
|
|
|
—
|
|
|
0.51
|
|
|||
|
Net income
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
1.42
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|||||
|
Continuing operations
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
0.91
|
|
|
Discontinued operations
|
—
|
|
|
—
|
|
|
0.51
|
|
|||
|
Net income
|
$
|
1.35
|
|
|
$
|
1.07
|
|
|
$
|
1.41
|
|
|
|
For the years ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Current
|
$
|
84
|
|
|
$
|
25
|
|
|
$
|
21
|
|
|
Deferred
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Excise tax
|
362
|
|
|
153
|
|
|
209
|
|
|||
|
Total income tax expense, including excise tax
|
$
|
446
|
|
|
$
|
178
|
|
|
$
|
230
|
|
|
•
|
Level 2-Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.
|
|
•
|
Level 3-Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.
|
|
|
|
|
As of December 31,
|
||||||||||||||
|
|
|
|
2018
|
|
2017
|
||||||||||||
|
|
Level in Fair Value Hierarchy
|
|
Carrying Value
|
|
Fair
Value
|
|
Carrying Value
|
|
Fair
Value |
||||||||
|
Financial assets:
|
|
|
|
|
|
|
|
|
|
||||||||
|
Loans held for investment
|
3
|
|
$
|
1,524,873
|
|
|
$
|
1,534,743
|
|
|
$
|
1,726,283
|
|
|
$
|
1,737,286
|
|
|
Financial liabilities:
|
|
|
|
|
|
|
|
|
|
||||||||
|
Secured funding agreements
|
2
|
|
$
|
777,974
|
|
|
$
|
777,974
|
|
|
$
|
957,960
|
|
|
$
|
957,960
|
|
|
Secured term loan
|
2
|
|
108,345
|
|
|
110,000
|
|
|
107,595
|
|
|
110,000
|
|
||||
|
Collateralized loan obligation securitization debt (consolidated VIE)
|
3
|
|
270,737
|
|
|
272,927
|
|
|
271,211
|
|
|
272,927
|
|
||||
|
|
Incurred
|
|
Payable
|
||||||||||||||||
|
|
For the years ended December 31,
|
|
As of December 31,
|
||||||||||||||||
|
|
2018
|
|
2017
|
|
2016
|
|
2018
|
|
2017
|
||||||||||
|
Affiliate Payments
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Management fees
|
$
|
6,268
|
|
|
$
|
6,188
|
|
|
$
|
5,608
|
|
|
$
|
1,576
|
|
|
$
|
1,549
|
|
|
Incentive fees
|
1,150
|
|
|
381
|
|
|
348
|
|
|
540
|
|
|
—
|
|
|||||
|
General and administrative expenses
|
3,570
|
|
|
3,899
|
|
|
3,441
|
|
|
996
|
|
|
1,016
|
|
|||||
|
Direct costs
|
224
|
|
(1)
|
304
|
|
(1)
|
848
|
|
(2)
|
51
|
|
|
63
|
|
|||||
|
Total
|
$
|
11,212
|
|
|
$
|
10,772
|
|
|
$
|
10,245
|
|
|
$
|
3,163
|
|
|
$
|
2,628
|
|
|
(1)
|
For the
years ended December 31, 2018 and 2017
, direct costs incurred are included within general and administrative expenses in the Company’s consolidated statements of operations.
|
|
(2)
|
For the year ended
December 31, 2016
, direct costs incurred are included within (i) general and administrative expenses of
$486 thousand
and (ii) interest expense of
$362 thousand
in the Company’s consolidated statements of operations.
|
|
Date Declared
|
|
Record Date
|
|
Payment Date
|
|
Per Share Amount
|
|
Total Amount
|
||||
|
October 30, 2018
|
|
December 28, 2018
|
|
January 15, 2019
|
|
$
|
0.31
|
|
|
$
|
8,914
|
|
|
July 26, 2018
|
|
September 28, 2018
|
|
October 16, 2018
|
|
0.29
|
|
|
8,323
|
|
||
|
May 1, 2018
|
|
June 29, 2018
|
|
July 17, 2018
|
|
0.28
|
|
|
8,036
|
|
||
|
March 1, 2018
|
|
March 29, 2018
|
|
April 17, 2018
|
|
0.28
|
|
|
8,008
|
|
||
|
Total cash dividends declared for the year ended December 31, 2018
|
|
|
|
|
|
$
|
1.16
|
|
|
$
|
33,281
|
|
|
November 1, 2017
|
|
December 29, 2017
|
|
January 16, 2018
|
|
$
|
0.27
|
|
|
$
|
7,722
|
|
|
August 3, 2017
|
|
September 29, 2017
|
|
October 16, 2017
|
|
0.27
|
|
|
7,717
|
|
||
|
May 2, 2017
|
|
June 30, 2017
|
|
July 17, 2017
|
|
0.27
|
|
|
7,718
|
|
||
|
March 7, 2017
|
|
March 31, 2017
|
|
April 17, 2017
|
|
0.27
|
|
|
7,690
|
|
||
|
Total cash dividends declared for the year ended December 31, 2017
|
|
|
|
|
|
$
|
1.08
|
|
|
$
|
30,847
|
|
|
November 3, 2016
|
|
December 30, 2016
|
|
January 17, 2017
|
|
$
|
0.26
|
|
|
$
|
7,406
|
|
|
August 4, 2016
|
|
September 30, 2016
|
|
October 17, 2016
|
|
0.26
|
|
|
7,406
|
|
||
|
May 5, 2016
|
|
June 30, 2016
|
|
July 15, 2016
|
|
0.26
|
|
|
7,413
|
|
||
|
March 1, 2016
|
|
March 31, 2016
|
|
April 15, 2016
|
|
0.26
|
|
|
7,429
|
|
||
|
Total cash dividends declared for the year ended December 31, 2016
|
|
|
|
|
|
$
|
1.04
|
|
|
$
|
29,654
|
|
|
Mortgage banking revenue:
|
|
||
|
Servicing fees, net
|
$
|
11,081
|
|
|
Gains from mortgage banking activities
|
24,034
|
|
|
|
Provision for loss sharing
|
146
|
|
|
|
Change in fair value of mortgage servicing rights
|
(6,457
|
)
|
|
|
Mortgage banking revenue
|
28,804
|
|
|
|
Expenses:
|
|
||
|
Management fees to affiliate
|
446
|
|
|
|
Professional fees
|
718
|
|
|
|
Compensation and benefits
|
18,108
|
|
|
|
Transaction costs
|
797
|
|
|
|
General and administrative expenses
|
3,049
|
|
|
|
General and administrative expenses reimbursed to affiliate
|
622
|
|
|
|
Total expenses
|
23,740
|
|
|
|
Income from operations before income taxes
|
5,064
|
|
|
|
Income tax expense
|
843
|
|
|
|
Net income from operations of discontinued operations, net of income taxes
|
$
|
4,221
|
|
|
Current
|
$
|
(1,206
|
)
|
|
Deferred
|
2,049
|
|
|
|
Total income tax expense
|
$
|
843
|
|
|
Federal statutory rate
|
35.0
|
%
|
|
State income taxes
|
4.4
|
%
|
|
Federal benefit of state tax deduction
|
(1.5
|
)%
|
|
Effective tax rate
|
37.9
|
%
|
|
Affiliate Payments
|
|
||
|
Management fees (1)
|
$
|
446
|
|
|
General and administrative expenses (1)
|
622
|
|
|
|
Direct costs (1)
|
68
|
|
|
|
Total
|
$
|
1,136
|
|
|
(1)
|
Management fees incurred are included within management fees to affiliate, general and administrative expenses incurred are included within general and administrative expenses reimbursed to affiliate and direct costs incurred are included within general and administrative expenses for the year ended December 31, 2016 in the reconciliation of net income from operations of discontinued operations, net of income taxes.
|
|
|
For the three month period ended,
|
||||||||||||||
|
|
March 31
|
|
June 30
|
|
September 30
|
|
December 31
|
||||||||
|
2018:
|
|
|
|
|
|
|
|
||||||||
|
Net interest margin
|
$
|
13,137
|
|
|
$
|
13,636
|
|
|
$
|
13,984
|
|
|
$
|
14,525
|
|
|
Net income attributable to common stockholders
|
$
|
9,318
|
|
|
$
|
9,303
|
|
|
$
|
9,957
|
|
|
$
|
10,018
|
|
|
Net income per common share-Basic and Diluted
|
$
|
0.33
|
|
|
$
|
0.33
|
|
|
$
|
0.35
|
|
|
$
|
0.35
|
|
|
2017:
|
|
|
|
|
|
|
|
||||||||
|
Net interest margin
|
$
|
10,339
|
|
|
$
|
10,411
|
|
|
$
|
14,726
|
|
|
$
|
10,872
|
|
|
Net income attributable to common stockholders
|
$
|
6,453
|
|
|
$
|
6,713
|
|
|
$
|
11,058
|
|
|
$
|
6,183
|
|
|
Net income per common share-Basic and Diluted
|
$
|
0.23
|
|
|
$
|
0.24
|
|
|
$
|
0.39
|
|
|
$
|
0.22
|
|
|
|
|
ARES COMMERCIAL REAL ESTATE CORPORATION
|
|
|
|
|
|
|
|
Dated:
|
February 21, 2019
|
By:
|
/s/ James A. Henderson
|
|
|
|
|
James A. Henderson
|
|
|
|
|
Chief Executive Officer, Chief Investment Officer and President
(Principal Executive Officer)
|
|
|
|
|
|
|
Dated:
|
February 21, 2019
|
By:
|
/s/ Tae-Sik Yoon
|
|
|
|
|
Tae-Sik Yoon
|
|
|
|
|
Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)
|
|
Dated:
|
February 21, 2019
|
By:
|
/s/ James A. Henderson
|
|
|
|
|
James A. Henderson
Chief Executive Officer, Director, Chief Investment Officer and President
(Principal Executive Officer)
|
|
Dated:
|
February 21, 2019
|
By:
|
/s/ Tae-Sik Yoon
|
|
|
|
|
Tae-Sik Yoon
Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) |
|
Dated:
|
February 21, 2019
|
By:
|
/s/ William S. Benjamin
|
|
|
|
|
William S. Benjamin
Chairman, Director |
|
Dated:
|
February 21, 2019
|
By:
|
/s/ Rand S. April
|
|
|
|
|
Rand S. April
Director
|
|
Dated:
|
February 21, 2019
|
By:
|
/s/ Michael J Arougheti
|
|
|
|
|
Michael J Arougheti
Director
|
|
Dated:
|
February 21, 2019
|
By:
|
/s/ Caroline E. Blakely
|
|
|
|
|
Caroline E. Blakely
Director
|
|
Dated:
|
February 21, 2019
|
By:
|
/s/ William L. Browning
|
|
|
|
|
William L. Browning
Director
|
|
Dated:
|
February 21, 2019
|
By:
|
/s/ James E. Skinner
|
|
|
|
|
James E. Skinner
Director
|
|
Dated:
|
February 21, 2019
|
By:
|
/s/ Kirk A. Sykes
|
|
|
|
|
Kirk A. Sykes
Director
|
|
Dated:
|
February 21, 2019
|
By:
|
/s/ Edmond N. Moriarty, III
|
|
|
|
|
Edmond N. Moriarty, III
Director
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|